Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Interleukin-1 | 596 | 2023 | 966 | 37.950 |
Why?
|
Receptors, Interleukin-1 | 131 | 2022 | 228 | 13.050 |
Why?
|
Interleukin-18 | 109 | 2021 | 219 | 12.100 |
Why?
|
Inflammation | 173 | 2023 | 2480 | 10.860 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 152 | 2022 | 254 | 10.190 |
Why?
|
Cytokines | 195 | 2023 | 1841 | 10.030 |
Why?
|
Interleukin-1beta | 80 | 2021 | 370 | 9.880 |
Why?
|
Tumor Necrosis Factor-alpha | 242 | 2023 | 1140 | 8.900 |
Why?
|
Interleukins | 69 | 2023 | 236 | 8.060 |
Why?
|
Anti-Inflammatory Agents | 41 | 2023 | 447 | 6.470 |
Why?
|
Sialoglycoproteins | 96 | 2005 | 159 | 5.710 |
Why?
|
Leukocytes, Mononuclear | 107 | 2021 | 493 | 5.230 |
Why?
|
Immunity, Innate | 42 | 2023 | 720 | 4.850 |
Why?
|
Interleukin-6 | 92 | 2023 | 676 | 4.790 |
Why?
|
Interleukin-1alpha | 28 | 2021 | 55 | 4.720 |
Why?
|
NLR Family, Pyrin Domain-Containing 3 Protein | 30 | 2023 | 144 | 4.690 |
Why?
|
Inflammasomes | 25 | 2023 | 115 | 4.450 |
Why?
|
Monocytes | 104 | 2021 | 504 | 4.420 |
Why?
|
Lipopolysaccharides | 131 | 2022 | 823 | 4.370 |
Why?
|
Interferon-gamma | 82 | 2021 | 719 | 4.080 |
Why?
|
Animals | 562 | 2023 | 31709 | 3.990 |
Why?
|
Caspase 1 | 48 | 2018 | 140 | 3.940 |
Why?
|
Histone Deacetylase Inhibitors | 29 | 2019 | 198 | 3.620 |
Why?
|
alpha 1-Antitrypsin | 21 | 2020 | 103 | 3.540 |
Why?
|
Antirheumatic Agents | 21 | 2016 | 255 | 3.520 |
Why?
|
Mice | 304 | 2023 | 14872 | 3.390 |
Why?
|
Autoimmune Diseases | 26 | 2019 | 382 | 3.150 |
Why?
|
Recombinant Proteins | 145 | 2023 | 1230 | 3.000 |
Why?
|
Humans | 847 | 2023 | 114709 | 2.990 |
Why?
|
Antibodies, Monoclonal | 31 | 2023 | 1264 | 2.800 |
Why?
|
Fever | 64 | 2019 | 280 | 2.760 |
Why?
|
Inflammation Mediators | 34 | 2018 | 477 | 2.640 |
Why?
|
Glycoproteins | 41 | 2006 | 304 | 2.520 |
Why?
|
Colitis | 21 | 2022 | 223 | 2.360 |
Why?
|
Neutrophils | 52 | 2021 | 1176 | 2.330 |
Why?
|
Cells, Cultured | 150 | 2023 | 3886 | 2.290 |
Why?
|
Hydroxamic Acids | 23 | 2018 | 80 | 2.270 |
Why?
|
Mice, Inbred C57BL | 114 | 2023 | 4694 | 2.240 |
Why?
|
Intercellular Signaling Peptides and Proteins | 44 | 2023 | 351 | 2.170 |
Why?
|
Macrophages | 72 | 2023 | 1263 | 2.160 |
Why?
|
Signal Transduction | 74 | 2023 | 4516 | 2.150 |
Why?
|
Pyrogens | 52 | 2004 | 55 | 2.150 |
Why?
|
Endotoxins | 58 | 2004 | 211 | 2.140 |
Why?
|
Gene Expression Regulation | 61 | 2021 | 2320 | 2.140 |
Why?
|
Interleukin-8 | 38 | 2020 | 237 | 2.120 |
Why?
|
Receptors, Immunologic | 36 | 2011 | 201 | 2.010 |
Why?
|
Arthritis, Gouty | 7 | 2020 | 14 | 1.980 |
Why?
|
Renal Dialysis | 34 | 2009 | 374 | 1.960 |
Why?
|
Carrier Proteins | 22 | 2017 | 695 | 1.920 |
Why?
|
Receptors, Interleukin | 14 | 2022 | 39 | 1.670 |
Why?
|
RNA, Messenger | 93 | 2022 | 2553 | 1.650 |
Why?
|
Peritonitis | 7 | 2020 | 77 | 1.600 |
Why?
|
Arthritis, Experimental | 8 | 2019 | 130 | 1.590 |
Why?
|
Interleukin-17 | 9 | 2020 | 104 | 1.580 |
Why?
|
Adaptive Immunity | 10 | 2019 | 155 | 1.560 |
Why?
|
Dinoprostone | 42 | 2007 | 184 | 1.520 |
Why?
|
Melanoma | 11 | 2023 | 620 | 1.510 |
Why?
|
Nitriles | 7 | 2021 | 149 | 1.450 |
Why?
|
T-Lymphocytes | 62 | 2021 | 1737 | 1.440 |
Why?
|
Toll-Like Receptors | 16 | 2018 | 167 | 1.430 |
Why?
|
Shock, Septic | 25 | 2016 | 186 | 1.390 |
Why?
|
Cell Line | 76 | 2021 | 2637 | 1.380 |
Why?
|
Uric Acid | 7 | 2021 | 148 | 1.380 |
Why?
|
Rheumatic Diseases | 5 | 2019 | 49 | 1.360 |
Why?
|
Receptors, Interleukin-18 | 12 | 2021 | 15 | 1.360 |
Why?
|
Mice, Knockout | 69 | 2022 | 2570 | 1.350 |
Why?
|
Neoplasms | 30 | 2023 | 2097 | 1.340 |
Why?
|
Male | 302 | 2022 | 55609 | 1.330 |
Why?
|
Immune Tolerance | 10 | 2021 | 323 | 1.310 |
Why?
|
Disease Models, Animal | 52 | 2023 | 3535 | 1.280 |
Why?
|
Mice, Transgenic | 38 | 2022 | 1950 | 1.250 |
Why?
|
Interleukin-12 | 21 | 2018 | 110 | 1.250 |
Why?
|
Interleukin-18 Receptor alpha Subunit | 12 | 2016 | 12 | 1.250 |
Why?
|
Psoriasis | 6 | 2020 | 74 | 1.240 |
Why?
|
Autophagy | 6 | 2022 | 235 | 1.230 |
Why?
|
Receptors, Tumor Necrosis Factor | 24 | 2005 | 140 | 1.220 |
Why?
|
Proteins | 46 | 2008 | 908 | 1.220 |
Why?
|
Arthritis, Rheumatoid | 23 | 2019 | 1003 | 1.190 |
Why?
|
Recombinant Fusion Proteins | 16 | 2016 | 616 | 1.190 |
Why?
|
Receptors, Interleukin-1 Type I | 8 | 2020 | 22 | 1.160 |
Why?
|
Interleukin-1 Receptor Accessory Protein | 6 | 2019 | 9 | 1.160 |
Why?
|
STAT3 Transcription Factor | 7 | 2023 | 173 | 1.150 |
Why?
|
Lymphocyte Activation | 73 | 2021 | 1037 | 1.130 |
Why?
|
Immunologic Factors | 5 | 2021 | 220 | 1.120 |
Why?
|
Th1 Cells | 8 | 2013 | 123 | 1.120 |
Why?
|
Female | 249 | 2023 | 59523 | 1.100 |
Why?
|
NF-kappa B | 29 | 2021 | 641 | 1.070 |
Why?
|
Candida albicans | 9 | 2021 | 50 | 1.070 |
Why?
|
Biological Factors | 11 | 2019 | 35 | 1.060 |
Why?
|
Melanoma, Experimental | 10 | 2021 | 89 | 1.060 |
Why?
|
Graft vs Host Disease | 12 | 2018 | 212 | 1.030 |
Why?
|
Interleukin-2 | 42 | 1999 | 413 | 1.020 |
Why?
|
In Vitro Techniques | 69 | 2020 | 1016 | 1.000 |
Why?
|
Killer Cells, Natural | 28 | 2018 | 380 | 0.970 |
Why?
|
Kidney Failure, Chronic | 14 | 2009 | 489 | 0.960 |
Why?
|
Protein Biosynthesis | 32 | 1998 | 387 | 0.960 |
Why?
|
B-Lymphocytes | 12 | 2020 | 766 | 0.940 |
Why?
|
HIV-1 | 13 | 2013 | 768 | 0.940 |
Why?
|
Myocardial Infarction | 11 | 2016 | 927 | 0.940 |
Why?
|
Staphylococcus epidermidis | 15 | 2018 | 71 | 0.930 |
Why?
|
Receptors, Cell Surface | 16 | 2015 | 355 | 0.900 |
Why?
|
Dendritic Cells | 13 | 2021 | 435 | 0.890 |
Why?
|
Myeloid-Derived Suppressor Cells | 2 | 2021 | 56 | 0.890 |
Why?
|
Adult | 161 | 2022 | 30554 | 0.880 |
Why?
|
Antibodies | 16 | 2017 | 371 | 0.880 |
Why?
|
Cardiovascular Diseases | 7 | 2020 | 1727 | 0.870 |
Why?
|
Histone Deacetylases | 14 | 2018 | 195 | 0.870 |
Why?
|
Endotoxemia | 9 | 2017 | 86 | 0.870 |
Why?
|
Escherichia coli | 35 | 2014 | 720 | 0.860 |
Why?
|
Intestinal Mucosa | 9 | 2023 | 532 | 0.860 |
Why?
|
Protein Precursors | 12 | 2009 | 119 | 0.840 |
Why?
|
Gene Expression | 40 | 2021 | 1421 | 0.840 |
Why?
|
Exercise Tolerance | 4 | 2019 | 213 | 0.840 |
Why?
|
C-Reactive Protein | 18 | 2022 | 362 | 0.830 |
Why?
|
Rabbits | 77 | 2005 | 733 | 0.830 |
Why?
|
Antineoplastic Agents | 15 | 2019 | 1879 | 0.830 |
Why?
|
Antibodies, Monoclonal, Humanized | 11 | 2020 | 663 | 0.820 |
Why?
|
Membrane Glycoproteins | 13 | 2011 | 430 | 0.820 |
Why?
|
Antibodies, Neutralizing | 4 | 2021 | 222 | 0.800 |
Why?
|
Leukocytes | 29 | 2019 | 276 | 0.790 |
Why?
|
Wnt Signaling Pathway | 1 | 2023 | 146 | 0.790 |
Why?
|
Bacterial Toxins | 12 | 2002 | 103 | 0.790 |
Why?
|
Radioimmunoassay | 39 | 2003 | 162 | 0.790 |
Why?
|
T-Lymphocytes, Helper-Inducer | 10 | 2013 | 127 | 0.790 |
Why?
|
Blood Cells | 6 | 2009 | 38 | 0.790 |
Why?
|
Sepsis | 17 | 2016 | 509 | 0.780 |
Why?
|
Middle Aged | 121 | 2022 | 26738 | 0.770 |
Why?
|
Biomarkers | 32 | 2022 | 3408 | 0.770 |
Why?
|
Granulomatous Disease, Chronic | 5 | 2017 | 60 | 0.770 |
Why?
|
Interleukin-10 | 16 | 2019 | 299 | 0.770 |
Why?
|
Body Temperature | 26 | 2012 | 208 | 0.750 |
Why?
|
Immunity, Cellular | 6 | 2017 | 248 | 0.750 |
Why?
|
Inflammatory Bowel Diseases | 5 | 2022 | 284 | 0.750 |
Why?
|
Vitiligo | 3 | 2016 | 41 | 0.740 |
Why?
|
Heart Failure | 12 | 2021 | 1945 | 0.730 |
Why?
|
Endothelial Cells | 8 | 2021 | 687 | 0.730 |
Why?
|
Dose-Response Relationship, Drug | 52 | 2015 | 1842 | 0.730 |
Why?
|
Neovascularization, Pathologic | 11 | 2013 | 281 | 0.730 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 16 | 2015 | 260 | 0.730 |
Why?
|
Autoimmunity | 4 | 2019 | 813 | 0.710 |
Why?
|
Adipose Tissue | 7 | 2018 | 545 | 0.710 |
Why?
|
Transcription, Genetic | 28 | 2016 | 1313 | 0.690 |
Why?
|
Enzyme Inhibitors | 16 | 2015 | 750 | 0.690 |
Why?
|
Hematopoiesis | 9 | 2019 | 171 | 0.690 |
Why?
|
Protein Isoforms | 13 | 2015 | 338 | 0.690 |
Why?
|
Cysteine Endopeptidases | 8 | 2003 | 60 | 0.690 |
Why?
|
Toll-Like Receptor 4 | 15 | 2017 | 287 | 0.670 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 24 | 2022 | 797 | 0.660 |
Why?
|
Atherosclerosis | 7 | 2017 | 341 | 0.660 |
Why?
|
Obesity | 11 | 2018 | 2508 | 0.660 |
Why?
|
Antibodies, Blocking | 1 | 2019 | 32 | 0.660 |
Why?
|
Fibroblasts | 20 | 2010 | 838 | 0.660 |
Why?
|
Insulin Resistance | 7 | 2019 | 1072 | 0.660 |
Why?
|
Immunoglobulin Fc Fragments | 3 | 2016 | 35 | 0.650 |
Why?
|
Arthritis | 7 | 2020 | 109 | 0.640 |
Why?
|
Rats | 80 | 2018 | 4958 | 0.640 |
Why?
|
Mitogen-Activated Protein Kinases | 11 | 2004 | 278 | 0.630 |
Why?
|
Parkinson Disease | 1 | 2023 | 345 | 0.630 |
Why?
|
Islets of Langerhans | 16 | 2014 | 728 | 0.630 |
Why?
|
Acute-Phase Reaction | 18 | 2008 | 39 | 0.630 |
Why?
|
Up-Regulation | 18 | 2019 | 808 | 0.620 |
Why?
|
Ventricular Remodeling | 6 | 2021 | 226 | 0.620 |
Why?
|
Heterocyclic Compounds, 4 or More Rings | 1 | 2018 | 16 | 0.620 |
Why?
|
Aging | 12 | 2022 | 1618 | 0.620 |
Why?
|
Phagosomes | 3 | 2014 | 38 | 0.620 |
Why?
|
Communicable Diseases | 3 | 2017 | 129 | 0.620 |
Why?
|
Membranes, Artificial | 10 | 2003 | 65 | 0.620 |
Why?
|
Apoptosis | 23 | 2017 | 2363 | 0.620 |
Why?
|
Islets of Langerhans Transplantation | 3 | 2008 | 53 | 0.610 |
Why?
|
Endothelium, Vascular | 16 | 2017 | 847 | 0.610 |
Why?
|
Arthritis, Juvenile | 2 | 2011 | 42 | 0.600 |
Why?
|
Candidiasis | 7 | 2021 | 51 | 0.590 |
Why?
|
Gout | 5 | 2021 | 36 | 0.590 |
Why?
|
rho-Associated Kinases | 1 | 2018 | 80 | 0.590 |
Why?
|
Angiogenesis Inhibitors | 2 | 2010 | 214 | 0.590 |
Why?
|
Lymphocytes | 16 | 2019 | 330 | 0.580 |
Why?
|
Ibuprofen | 16 | 2007 | 75 | 0.580 |
Why?
|
MAP Kinase Signaling System | 5 | 2014 | 276 | 0.570 |
Why?
|
Acute Disease | 22 | 2018 | 911 | 0.570 |
Why?
|
Interleukin-33 | 5 | 2021 | 38 | 0.560 |
Why?
|
Aged | 73 | 2022 | 19074 | 0.560 |
Why?
|
Interferon-alpha | 7 | 2011 | 186 | 0.550 |
Why?
|
Multiple Myeloma | 5 | 2016 | 98 | 0.550 |
Why?
|
Allergy and Immunology | 3 | 2007 | 51 | 0.550 |
Why?
|
Adenosine Triphosphate | 3 | 2015 | 430 | 0.550 |
Why?
|
Mutation | 10 | 2019 | 3346 | 0.550 |
Why?
|
Immunoglobulin G | 12 | 2016 | 770 | 0.540 |
Why?
|
Mycobacterium tuberculosis | 6 | 2015 | 269 | 0.540 |
Why?
|
Overweight | 1 | 2020 | 472 | 0.540 |
Why?
|
Cell Line, Tumor | 21 | 2021 | 2711 | 0.540 |
Why?
|
Immunity, Humoral | 1 | 2017 | 112 | 0.530 |
Why?
|
Pneumonia | 4 | 2019 | 568 | 0.530 |
Why?
|
Liver | 37 | 2017 | 1637 | 0.530 |
Why?
|
Base Sequence | 31 | 2017 | 2114 | 0.530 |
Why?
|
Mice, Inbred BALB C | 31 | 2021 | 1144 | 0.530 |
Why?
|
Acetylmuramyl-Alanyl-Isoglutamine | 10 | 2009 | 12 | 0.530 |
Why?
|
Myeloid Cells | 8 | 2017 | 126 | 0.530 |
Why?
|
Gene Expression Regulation, Enzymologic | 4 | 2014 | 270 | 0.530 |
Why?
|
Molecular Targeted Therapy | 5 | 2020 | 347 | 0.520 |
Why?
|
Cyclooxygenase Inhibitors | 16 | 1996 | 72 | 0.520 |
Why?
|
Histocompatibility Antigens Class II | 4 | 2016 | 352 | 0.520 |
Why?
|
Behcet Syndrome | 3 | 2013 | 16 | 0.520 |
Why?
|
Myocardial Reperfusion Injury | 5 | 2016 | 95 | 0.510 |
Why?
|
Repressor Proteins | 4 | 2014 | 366 | 0.510 |
Why?
|
Prostaglandins E | 24 | 1990 | 44 | 0.510 |
Why?
|
Still's Disease, Adult-Onset | 3 | 2019 | 4 | 0.500 |
Why?
|
Chlamydophila pneumoniae | 5 | 2004 | 11 | 0.500 |
Why?
|
Hereditary Autoinflammatory Diseases | 2 | 2015 | 5 | 0.500 |
Why?
|
Caspase Inhibitors | 6 | 2016 | 78 | 0.500 |
Why?
|
Gout Suppressants | 1 | 2015 | 20 | 0.500 |
Why?
|
Cell Division | 33 | 2009 | 758 | 0.500 |
Why?
|
HLA-DQ Antigens | 1 | 2016 | 174 | 0.490 |
Why?
|
Aortic Valve Stenosis | 4 | 2023 | 272 | 0.490 |
Why?
|
HLA-DR Antigens | 2 | 2016 | 219 | 0.480 |
Why?
|
CD4-Positive T-Lymphocytes | 7 | 2019 | 959 | 0.480 |
Why?
|
Metabolic Syndrome | 1 | 2018 | 321 | 0.480 |
Why?
|
Lectins, C-Type | 6 | 2018 | 61 | 0.480 |
Why?
|
Lymphokines | 18 | 1996 | 111 | 0.480 |
Why?
|
Polymorphism, Genetic | 5 | 2020 | 610 | 0.470 |
Why?
|
Macrophages, Peritoneal | 12 | 2019 | 93 | 0.470 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 10 | 2015 | 299 | 0.470 |
Why?
|
Time Factors | 52 | 2017 | 6116 | 0.470 |
Why?
|
Molecular Sequence Data | 32 | 2011 | 2785 | 0.470 |
Why?
|
Rheumatology | 1 | 2016 | 88 | 0.470 |
Why?
|
Dextran Sulfate | 8 | 2022 | 70 | 0.470 |
Why?
|
Aortic Valve | 5 | 2023 | 398 | 0.470 |
Why?
|
Receptors, Cytokine | 6 | 2019 | 33 | 0.460 |
Why?
|
Epigenesis, Genetic | 7 | 2021 | 521 | 0.460 |
Why?
|
Growth Substances | 18 | 2002 | 138 | 0.460 |
Why?
|
Lung | 22 | 2021 | 3561 | 0.460 |
Why?
|
Amino Acid Sequence | 24 | 2020 | 1982 | 0.460 |
Why?
|
Hepatitis | 5 | 2021 | 45 | 0.460 |
Why?
|
Hot Temperature | 6 | 2012 | 302 | 0.450 |
Why?
|
Hidradenitis Suppurativa | 3 | 2020 | 9 | 0.450 |
Why?
|
Macrophage Activation Syndrome | 4 | 2021 | 12 | 0.450 |
Why?
|
Kinetics | 40 | 2012 | 1551 | 0.450 |
Why?
|
Metabolome | 1 | 2017 | 282 | 0.450 |
Why?
|
Neoplasm Metastasis | 3 | 2013 | 523 | 0.450 |
Why?
|
Models, Biological | 15 | 2016 | 1621 | 0.450 |
Why?
|
Cell Nucleus | 6 | 2019 | 554 | 0.440 |
Why?
|
Diabetes Mellitus, Type 1 | 16 | 2019 | 3256 | 0.440 |
Why?
|
Toll-Like Receptor 2 | 9 | 2016 | 110 | 0.440 |
Why?
|
Promoter Regions, Genetic | 10 | 2017 | 1131 | 0.440 |
Why?
|
Protein Binding | 16 | 2018 | 1890 | 0.440 |
Why?
|
Disease | 5 | 2011 | 85 | 0.430 |
Why?
|
Insulin-Secreting Cells | 6 | 2014 | 317 | 0.430 |
Why?
|
Rare Diseases | 1 | 2014 | 89 | 0.430 |
Why?
|
HIV Infections | 8 | 2021 | 2469 | 0.420 |
Why?
|
Electrocardiography | 3 | 2014 | 560 | 0.420 |
Why?
|
Interferons | 10 | 2023 | 151 | 0.420 |
Why?
|
Antigens, CD | 12 | 2015 | 442 | 0.410 |
Why?
|
Superantigens | 7 | 2001 | 69 | 0.410 |
Why?
|
Complement C3 | 2 | 2013 | 188 | 0.410 |
Why?
|
Receptors, CXCR4 | 2 | 2010 | 78 | 0.410 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2012 | 71 | 0.400 |
Why?
|
Alzheimer Disease | 5 | 2022 | 442 | 0.400 |
Why?
|
Spinal Cord Injuries | 3 | 2021 | 174 | 0.400 |
Why?
|
Whole-Body Irradiation | 1 | 2012 | 73 | 0.400 |
Why?
|
Blood Platelets | 5 | 2018 | 351 | 0.400 |
Why?
|
T-Lymphocytes, Regulatory | 9 | 2021 | 339 | 0.400 |
Why?
|
Escherichia coli Infections | 4 | 2000 | 100 | 0.400 |
Why?
|
Familial Mediterranean Fever | 4 | 2009 | 6 | 0.400 |
Why?
|
Apoptosis Regulatory Proteins | 5 | 2017 | 171 | 0.400 |
Why?
|
Bacterial Infections | 7 | 2004 | 218 | 0.390 |
Why?
|
Immunotherapy | 11 | 2021 | 474 | 0.390 |
Why?
|
Muscle, Skeletal | 3 | 2017 | 1473 | 0.390 |
Why?
|
Virulence Factors | 5 | 2022 | 139 | 0.390 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 4 | 2021 | 51 | 0.390 |
Why?
|
Lipid Metabolism | 4 | 2011 | 444 | 0.390 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 4 | 2006 | 34 | 0.390 |
Why?
|
Virus Replication | 8 | 2011 | 395 | 0.390 |
Why?
|
RNA, Small Interfering | 10 | 2015 | 535 | 0.390 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2019 | 2096 | 0.380 |
Why?
|
Heart Diseases | 5 | 2014 | 331 | 0.380 |
Why?
|
Interferon Type I | 17 | 1998 | 128 | 0.380 |
Why?
|
Cloning, Molecular | 16 | 2008 | 522 | 0.380 |
Why?
|
Adaptor Proteins, Signal Transducing | 5 | 2017 | 367 | 0.380 |
Why?
|
Tumor Cells, Cultured | 22 | 2012 | 850 | 0.380 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 14 | 2002 | 140 | 0.380 |
Why?
|
Sulfones | 6 | 2021 | 97 | 0.380 |
Why?
|
Chronic Disease | 15 | 2021 | 1578 | 0.380 |
Why?
|
Interleukin-4 | 11 | 1996 | 206 | 0.380 |
Why?
|
Analysis of Variance | 15 | 2011 | 1226 | 0.370 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 15 | 2016 | 923 | 0.370 |
Why?
|
Acute Coronary Syndrome | 1 | 2014 | 253 | 0.370 |
Why?
|
Myocardium | 13 | 2018 | 913 | 0.370 |
Why?
|
Chemokines | 12 | 2016 | 216 | 0.370 |
Why?
|
Drug Synergism | 26 | 2016 | 317 | 0.370 |
Why?
|
Immunosuppressive Agents | 9 | 2013 | 646 | 0.360 |
Why?
|
Histamine | 7 | 1994 | 56 | 0.360 |
Why?
|
Immune Sera | 12 | 2001 | 79 | 0.360 |
Why?
|
Intercellular Adhesion Molecule-1 | 9 | 2017 | 154 | 0.360 |
Why?
|
Tuberculosis | 5 | 2015 | 241 | 0.360 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 7 | 1999 | 172 | 0.360 |
Why?
|
Epithelial Cells | 9 | 2016 | 951 | 0.360 |
Why?
|
Interferon Inducers | 4 | 1999 | 7 | 0.360 |
Why?
|
Arteriosclerosis | 6 | 2003 | 83 | 0.360 |
Why?
|
Biological Assay | 13 | 2008 | 112 | 0.350 |
Why?
|
Anti-HIV Agents | 5 | 2021 | 666 | 0.350 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2022 | 1880 | 0.350 |
Why?
|
Fatigue Syndrome, Chronic | 3 | 2017 | 16 | 0.350 |
Why?
|
Breast Neoplasms | 2 | 2018 | 1862 | 0.350 |
Why?
|
CCR5 Receptor Antagonists | 1 | 2010 | 6 | 0.350 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2017 | 520 | 0.350 |
Why?
|
Calcinosis | 3 | 2022 | 242 | 0.350 |
Why?
|
Treatment Outcome | 22 | 2020 | 9088 | 0.350 |
Why?
|
Aspergillosis | 3 | 2016 | 23 | 0.350 |
Why?
|
Transplantation Tolerance | 2 | 2011 | 30 | 0.340 |
Why?
|
Myocardial Ischemia | 5 | 2009 | 235 | 0.340 |
Why?
|
Reactive Oxygen Species | 8 | 2023 | 531 | 0.340 |
Why?
|
Double-Blind Method | 19 | 2016 | 1660 | 0.340 |
Why?
|
Liver Cirrhosis | 4 | 2021 | 227 | 0.340 |
Why?
|
HEK293 Cells | 4 | 2021 | 591 | 0.340 |
Why?
|
Sodium Chloride | 3 | 2009 | 136 | 0.340 |
Why?
|
Concanavalin A | 13 | 2006 | 74 | 0.330 |
Why?
|
Synovial Membrane | 5 | 2016 | 75 | 0.330 |
Why?
|
beta 2-Microglobulin | 1 | 2009 | 45 | 0.330 |
Why?
|
Lipopolysaccharide Receptors | 5 | 2015 | 81 | 0.330 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2009 | 17 | 0.330 |
Why?
|
Aspirin | 3 | 2000 | 324 | 0.330 |
Why?
|
Protein Processing, Post-Translational | 9 | 2017 | 399 | 0.330 |
Why?
|
Peritoneal Dialysis, Continuous Ambulatory | 7 | 1995 | 13 | 0.330 |
Why?
|
Terminology as Topic | 1 | 2010 | 187 | 0.330 |
Why?
|
Myocarditis | 3 | 2016 | 93 | 0.330 |
Why?
|
Enzyme Activation | 8 | 2015 | 785 | 0.330 |
Why?
|
beta-Glucans | 4 | 2021 | 19 | 0.330 |
Why?
|
Primary Cell Culture | 5 | 2021 | 150 | 0.320 |
Why?
|
Toxemia | 3 | 1994 | 5 | 0.320 |
Why?
|
Adolescent | 46 | 2018 | 17855 | 0.320 |
Why?
|
Receptors, Histamine H2 | 3 | 1994 | 8 | 0.320 |
Why?
|
Stem Cells | 3 | 2023 | 546 | 0.320 |
Why?
|
Sodium, Dietary | 1 | 2009 | 36 | 0.320 |
Why?
|
Myeloblastin | 4 | 2016 | 8 | 0.320 |
Why?
|
Cell Movement | 11 | 2018 | 869 | 0.310 |
Why?
|
Cognitive Dysfunction | 3 | 2022 | 284 | 0.310 |
Why?
|
Muscle, Smooth, Vascular | 6 | 2003 | 411 | 0.310 |
Why?
|
Cell Adhesion | 16 | 2003 | 432 | 0.310 |
Why?
|
Choroidal Neovascularization | 1 | 2009 | 44 | 0.310 |
Why?
|
Haplotypes | 5 | 2016 | 448 | 0.310 |
Why?
|
Macrophages, Alveolar | 6 | 2017 | 348 | 0.310 |
Why?
|
Blotting, Western | 16 | 2016 | 1147 | 0.310 |
Why?
|
Acute-Phase Proteins | 13 | 2002 | 64 | 0.310 |
Why?
|
Complement C5a | 10 | 1994 | 59 | 0.310 |
Why?
|
Transfection | 14 | 2015 | 866 | 0.310 |
Why?
|
Cell Differentiation | 14 | 2021 | 1701 | 0.310 |
Why?
|
Liver Diseases, Alcoholic | 2 | 2020 | 81 | 0.310 |
Why?
|
Prostaglandins | 15 | 1993 | 77 | 0.300 |
Why?
|
Lupus Erythematosus, Systemic | 6 | 2011 | 219 | 0.300 |
Why?
|
Alarmins | 2 | 2018 | 25 | 0.290 |
Why?
|
Immunologic Surveillance | 2 | 2010 | 19 | 0.290 |
Why?
|
Respiratory Mucosa | 3 | 2016 | 251 | 0.290 |
Why?
|
Liver Neoplasms | 8 | 2011 | 506 | 0.290 |
Why?
|
Receptors, Purinergic P2X7 | 4 | 2015 | 11 | 0.290 |
Why?
|
Th17 Cells | 3 | 2012 | 58 | 0.290 |
Why?
|
History, 20th Century | 6 | 2011 | 264 | 0.290 |
Why?
|
Weight Loss | 5 | 2022 | 642 | 0.290 |
Why?
|
Protein Structure, Tertiary | 7 | 2015 | 796 | 0.290 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2008 | 61 | 0.290 |
Why?
|
Tumor Escape | 2 | 2010 | 35 | 0.290 |
Why?
|
Leishmania braziliensis | 2 | 2017 | 2 | 0.290 |
Why?
|
Leishmania mexicana | 2 | 2017 | 2 | 0.290 |
Why?
|
Mitochondria | 3 | 2022 | 747 | 0.290 |
Why?
|
Obstetric Labor, Premature | 3 | 1999 | 33 | 0.290 |
Why?
|
Multienzyme Complexes | 1 | 2007 | 64 | 0.290 |
Why?
|
Severity of Illness Index | 14 | 2018 | 2540 | 0.280 |
Why?
|
Cellulose | 9 | 1996 | 57 | 0.280 |
Why?
|
Adjuvants, Immunologic | 10 | 2003 | 206 | 0.280 |
Why?
|
I-kappa B Proteins | 4 | 2005 | 79 | 0.280 |
Why?
|
Chlamydophila Infections | 2 | 2004 | 4 | 0.280 |
Why?
|
Young Adult | 18 | 2020 | 10472 | 0.280 |
Why?
|
Brain | 18 | 2021 | 2371 | 0.280 |
Why?
|
Aspergillus fumigatus | 4 | 2016 | 20 | 0.280 |
Why?
|
Colony-Stimulating Factors | 8 | 2018 | 32 | 0.280 |
Why?
|
Dexamethasone | 7 | 2023 | 317 | 0.280 |
Why?
|
Oligonucleotides, Antisense | 2 | 1999 | 100 | 0.280 |
Why?
|
Receptor, Nerve Growth Factor | 1 | 2006 | 3 | 0.270 |
Why?
|
Receptors, Pattern Recognition | 1 | 2006 | 9 | 0.270 |
Why?
|
Body Temperature Regulation | 8 | 1999 | 72 | 0.270 |
Why?
|
Chemokine CXCL1 | 6 | 2021 | 68 | 0.270 |
Why?
|
Serine Proteinase Inhibitors | 4 | 2016 | 34 | 0.270 |
Why?
|
Transplantation Conditioning | 4 | 2017 | 151 | 0.270 |
Why?
|
Keratinocytes | 5 | 2020 | 216 | 0.270 |
Why?
|
Mice, Mutant Strains | 11 | 2014 | 271 | 0.270 |
Why?
|
Caspase 3 | 7 | 2014 | 235 | 0.270 |
Why?
|
Homeostasis | 4 | 2023 | 573 | 0.270 |
Why?
|
Hypotension | 4 | 2010 | 116 | 0.260 |
Why?
|
Leukocyte Count | 22 | 2006 | 293 | 0.260 |
Why?
|
HIV Core Protein p24 | 8 | 2013 | 28 | 0.260 |
Why?
|
Neutrophil Activation | 1 | 2006 | 94 | 0.260 |
Why?
|
Models, Immunological | 3 | 2021 | 92 | 0.260 |
Why?
|
Leukemia, Myeloid | 5 | 1999 | 40 | 0.250 |
Why?
|
Muscles | 9 | 1996 | 320 | 0.250 |
Why?
|
Blood Proteins | 7 | 1994 | 231 | 0.250 |
Why?
|
Zymosan | 4 | 1998 | 64 | 0.250 |
Why?
|
Intracellular Space | 2 | 2018 | 68 | 0.250 |
Why?
|
Injections, Intraperitoneal | 8 | 2015 | 99 | 0.250 |
Why?
|
Adalimumab | 3 | 2020 | 44 | 0.250 |
Why?
|
Nitric Oxide | 11 | 2017 | 823 | 0.250 |
Why?
|
Skin | 10 | 2019 | 655 | 0.250 |
Why?
|
Alleles | 6 | 2017 | 789 | 0.250 |
Why?
|
Spleen | 13 | 2017 | 487 | 0.250 |
Why?
|
Chemotaxis, Leukocyte | 7 | 2011 | 130 | 0.250 |
Why?
|
Ventricular Function, Left | 5 | 2017 | 467 | 0.250 |
Why?
|
Phytohemagglutinins | 13 | 1996 | 27 | 0.240 |
Why?
|
Suppressor of Cytokine Signaling 1 Protein | 2 | 2019 | 11 | 0.240 |
Why?
|
Flow Cytometry | 10 | 2015 | 1083 | 0.240 |
Why?
|
Angiopoietins | 2 | 2015 | 12 | 0.240 |
Why?
|
Cytotoxicity, Immunologic | 12 | 2014 | 195 | 0.240 |
Why?
|
Pseudomonas Infections | 6 | 2016 | 184 | 0.240 |
Why?
|
Pilot Projects | 10 | 2016 | 1373 | 0.240 |
Why?
|
Tacrolimus | 2 | 2017 | 134 | 0.240 |
Why?
|
Mice, Inbred C3H | 20 | 2008 | 239 | 0.240 |
Why?
|
Immune System | 4 | 2016 | 172 | 0.240 |
Why?
|
Tetradecanoylphorbol Acetate | 14 | 1996 | 153 | 0.240 |
Why?
|
Myocardial Contraction | 6 | 2012 | 313 | 0.240 |
Why?
|
Acute Kidney Injury | 6 | 2017 | 638 | 0.240 |
Why?
|
Agranulocytosis | 3 | 1989 | 31 | 0.230 |
Why?
|
Neutralization Tests | 6 | 2015 | 63 | 0.230 |
Why?
|
Cryopyrin-Associated Periodic Syndromes | 2 | 2015 | 6 | 0.230 |
Why?
|
Phosphorylation | 8 | 2018 | 1569 | 0.230 |
Why?
|
Glycolysis | 3 | 2021 | 227 | 0.230 |
Why?
|
Leptin | 7 | 2008 | 210 | 0.230 |
Why?
|
Diet, High-Fat | 4 | 2018 | 225 | 0.230 |
Why?
|
Real-Time Polymerase Chain Reaction | 6 | 2014 | 314 | 0.230 |
Why?
|
Orthomyxoviridae Infections | 2 | 2016 | 54 | 0.230 |
Why?
|
Liver Diseases | 6 | 2016 | 255 | 0.230 |
Why?
|
Exercise Test | 3 | 2017 | 544 | 0.230 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2014 | 72 | 0.230 |
Why?
|
Cell Wall | 5 | 2016 | 52 | 0.230 |
Why?
|
Down-Regulation | 8 | 2020 | 594 | 0.230 |
Why?
|
Ultrafiltration | 5 | 1996 | 27 | 0.230 |
Why?
|
Tumor Burden | 3 | 2021 | 259 | 0.220 |
Why?
|
Cell Communication | 5 | 2021 | 280 | 0.220 |
Why?
|
Macrophage Inflammatory Proteins | 3 | 2005 | 12 | 0.220 |
Why?
|
Spinal Cord | 3 | 2021 | 347 | 0.220 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 5 | 2004 | 58 | 0.220 |
Why?
|
Intestines | 2 | 2017 | 326 | 0.220 |
Why?
|
Bone Marrow Transplantation | 5 | 2011 | 239 | 0.220 |
Why?
|
Host-Pathogen Interactions | 4 | 2021 | 295 | 0.220 |
Why?
|
Multigene Family | 6 | 2019 | 190 | 0.220 |
Why?
|
Solubility | 11 | 2007 | 223 | 0.220 |
Why?
|
Glycation End Products, Advanced | 1 | 2004 | 57 | 0.220 |
Why?
|
Transforming Growth Factor beta | 7 | 2021 | 448 | 0.220 |
Why?
|
Non-alcoholic Fatty Liver Disease | 2 | 2017 | 245 | 0.220 |
Why?
|
Immobilized Proteins | 2 | 2015 | 11 | 0.220 |
Why?
|
Transplantation, Homologous | 8 | 2016 | 377 | 0.220 |
Why?
|
Pseudomonas aeruginosa | 8 | 2016 | 298 | 0.220 |
Why?
|
Glucose | 10 | 2019 | 897 | 0.220 |
Why?
|
RNA Stability | 1 | 2004 | 90 | 0.220 |
Why?
|
Enterotoxins | 7 | 2001 | 88 | 0.220 |
Why?
|
Ventricular Dysfunction, Left | 5 | 2018 | 358 | 0.220 |
Why?
|
Hypothalamus | 8 | 1997 | 147 | 0.220 |
Why?
|
Endothelium | 11 | 1989 | 111 | 0.220 |
Why?
|
Fibrosarcoma | 4 | 2007 | 20 | 0.220 |
Why?
|
Survival Analysis | 11 | 2020 | 1211 | 0.220 |
Why?
|
Liver Neoplasms, Experimental | 2 | 2003 | 26 | 0.220 |
Why?
|
alpha-Synuclein | 1 | 2023 | 21 | 0.220 |
Why?
|
CHO Cells | 5 | 2013 | 138 | 0.220 |
Why?
|
Nod2 Signaling Adaptor Protein | 5 | 2013 | 30 | 0.210 |
Why?
|
Macrophage Activation | 10 | 2015 | 164 | 0.210 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2015 | 308 | 0.210 |
Why?
|
Crohn Disease | 5 | 2006 | 196 | 0.210 |
Why?
|
Hypersensitivity | 4 | 2018 | 252 | 0.210 |
Why?
|
Neoplasms, Experimental | 4 | 2010 | 151 | 0.210 |
Why?
|
Cricetinae | 5 | 2013 | 253 | 0.210 |
Why?
|
Pulmonary Alveoli | 5 | 2012 | 373 | 0.210 |
Why?
|
Reference Values | 10 | 2022 | 743 | 0.210 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 3 | 2013 | 35 | 0.210 |
Why?
|
Hemodiafiltration | 1 | 2003 | 9 | 0.210 |
Why?
|
Organoids | 1 | 2023 | 74 | 0.210 |
Why?
|
Follow-Up Studies | 12 | 2017 | 4411 | 0.210 |
Why?
|
Serine Endopeptidases | 3 | 2016 | 102 | 0.210 |
Why?
|
Cyclooxygenase 2 | 5 | 2005 | 164 | 0.210 |
Why?
|
Stress, Physiological | 2 | 2017 | 378 | 0.210 |
Why?
|
Dopaminergic Neurons | 1 | 2023 | 43 | 0.210 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 6 | 2006 | 73 | 0.210 |
Why?
|
Serpins | 1 | 2022 | 25 | 0.210 |
Why?
|
Platelet Activation | 4 | 2018 | 68 | 0.210 |
Why?
|
Serum Amyloid A Protein | 10 | 2011 | 29 | 0.210 |
Why?
|
Nitric Oxide Synthase | 4 | 2002 | 209 | 0.200 |
Why?
|
Nerve Tissue Proteins | 4 | 1996 | 530 | 0.200 |
Why?
|
Borrelia burgdorferi Group | 2 | 1992 | 8 | 0.200 |
Why?
|
Muscle Proteins | 4 | 1996 | 210 | 0.200 |
Why?
|
Corticosterone | 9 | 2005 | 211 | 0.200 |
Why?
|
Drug Design | 3 | 2012 | 148 | 0.200 |
Why?
|
Drug Resistance | 5 | 2013 | 158 | 0.200 |
Why?
|
DNA | 14 | 2008 | 1352 | 0.200 |
Why?
|
Indomethacin | 18 | 1996 | 70 | 0.200 |
Why?
|
Reperfusion Injury | 3 | 2017 | 255 | 0.200 |
Why?
|
Ovalbumin | 3 | 2019 | 161 | 0.200 |
Why?
|
DNA-Binding Proteins | 10 | 2005 | 1314 | 0.200 |
Why?
|
Case-Control Studies | 11 | 2021 | 3004 | 0.200 |
Why?
|
Kidney Tubular Necrosis, Acute | 2 | 2017 | 22 | 0.200 |
Why?
|
Body Weight | 7 | 2018 | 869 | 0.200 |
Why?
|
Aged, 80 and over | 21 | 2020 | 6347 | 0.200 |
Why?
|
Anorexia | 3 | 1995 | 18 | 0.200 |
Why?
|
Lymph Nodes | 7 | 2017 | 419 | 0.200 |
Why?
|
Drosophila Proteins | 2 | 2002 | 164 | 0.200 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2020 | 1214 | 0.200 |
Why?
|
Molecular Weight | 15 | 2006 | 331 | 0.200 |
Why?
|
RNA-Binding Proteins | 4 | 2021 | 345 | 0.200 |
Why?
|
Proteostasis | 1 | 2022 | 20 | 0.190 |
Why?
|
Erdheim-Chester Disease | 1 | 2021 | 5 | 0.190 |
Why?
|
Hematopoietic Stem Cells | 4 | 2014 | 343 | 0.190 |
Why?
|
Pneumonia, Pneumococcal | 2 | 2017 | 38 | 0.190 |
Why?
|
Immunity | 6 | 2021 | 121 | 0.190 |
Why?
|
Leukocyte Elastase | 4 | 2016 | 80 | 0.190 |
Why?
|
Isoenzymes | 4 | 2004 | 283 | 0.190 |
Why?
|
Cell Proliferation | 7 | 2021 | 2187 | 0.190 |
Why?
|
Microglia | 3 | 2022 | 202 | 0.190 |
Why?
|
Dietary Fats | 3 | 2014 | 287 | 0.190 |
Why?
|
Cell Death | 5 | 2015 | 323 | 0.190 |
Why?
|
Neutrophil Infiltration | 5 | 2020 | 96 | 0.190 |
Why?
|
Glucose Tolerance Test | 4 | 2018 | 343 | 0.190 |
Why?
|
Structure-Activity Relationship | 10 | 2003 | 502 | 0.190 |
Why?
|
Cholesterol, HDL | 3 | 2018 | 183 | 0.190 |
Why?
|
Peptide Fragments | 5 | 2015 | 666 | 0.190 |
Why?
|
Binding Sites | 7 | 2003 | 1168 | 0.190 |
Why?
|
Umbilical Veins | 8 | 2009 | 58 | 0.190 |
Why?
|
Disease Progression | 9 | 2017 | 2381 | 0.190 |
Why?
|
Hemodynamics | 9 | 2018 | 1012 | 0.190 |
Why?
|
Limulus Test | 7 | 1989 | 8 | 0.190 |
Why?
|
Phagocytosis | 13 | 2015 | 350 | 0.190 |
Why?
|
Thyroid Neoplasms | 2 | 2015 | 264 | 0.190 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 3 | 2014 | 44 | 0.190 |
Why?
|
Polymerase Chain Reaction | 12 | 2011 | 993 | 0.190 |
Why?
|
Staphylococcus aureus | 5 | 2003 | 389 | 0.190 |
Why?
|
Myeloid Differentiation Factor 88 | 3 | 2018 | 90 | 0.190 |
Why?
|
Fatty Acids | 7 | 1998 | 381 | 0.180 |
Why?
|
Acute Lung Injury | 3 | 2016 | 299 | 0.180 |
Why?
|
Eating | 5 | 2018 | 344 | 0.180 |
Why?
|
Kupffer Cells | 1 | 2021 | 45 | 0.180 |
Why?
|
Kidney | 10 | 2017 | 1188 | 0.180 |
Why?
|
Culture Media | 12 | 2011 | 155 | 0.180 |
Why?
|
Brain Injuries | 3 | 2015 | 461 | 0.180 |
Why?
|
Leishmaniasis, Visceral | 2 | 2018 | 5 | 0.180 |
Why?
|
Antigens | 3 | 2013 | 318 | 0.180 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 1 | 2021 | 25 | 0.180 |
Why?
|
Gene Deletion | 1 | 2022 | 356 | 0.180 |
Why?
|
Energy Metabolism | 7 | 2018 | 731 | 0.180 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 | 1994 | 95 | 0.180 |
Why?
|
Genotype | 5 | 2020 | 1760 | 0.180 |
Why?
|
Shock | 3 | 1991 | 84 | 0.180 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2021 | 360 | 0.180 |
Why?
|
Cell- and Tissue-Based Therapy | 1 | 2021 | 56 | 0.180 |
Why?
|
Pulmonary Emphysema | 2 | 2013 | 272 | 0.180 |
Why?
|
Immunity, Mucosal | 1 | 2021 | 84 | 0.170 |
Why?
|
Immunologic Memory | 2 | 2021 | 313 | 0.170 |
Why?
|
Toll-Like Receptor 9 | 2 | 2018 | 30 | 0.170 |
Why?
|
Pyrazoles | 3 | 2021 | 362 | 0.170 |
Why?
|
Interleukin-23 | 2 | 2011 | 15 | 0.170 |
Why?
|
Parvovirus | 3 | 2017 | 13 | 0.170 |
Why?
|
Polymers | 5 | 2007 | 448 | 0.170 |
Why?
|
Antigens, CD19 | 1 | 2020 | 91 | 0.170 |
Why?
|
Protein Transport | 3 | 2019 | 395 | 0.170 |
Why?
|
NADPH Oxidases | 4 | 2014 | 120 | 0.170 |
Why?
|
Antiviral Agents | 4 | 2016 | 645 | 0.170 |
Why?
|
Lyme Disease | 2 | 2018 | 32 | 0.170 |
Why?
|
Cytoskeletal Proteins | 2 | 2012 | 145 | 0.170 |
Why?
|
Eligibility Determination | 1 | 2020 | 60 | 0.170 |
Why?
|
Myelin Sheath | 1 | 2021 | 144 | 0.170 |
Why?
|
Cohort Studies | 8 | 2020 | 4895 | 0.170 |
Why?
|
Membrane Proteins | 8 | 2021 | 1019 | 0.170 |
Why?
|
Hepatocytes | 3 | 2018 | 195 | 0.170 |
Why?
|
Phosphoproteins | 6 | 2009 | 298 | 0.170 |
Why?
|
Myocytes, Cardiac | 3 | 2018 | 449 | 0.170 |
Why?
|
Human Genome Project | 2 | 2016 | 14 | 0.170 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2021 | 69 | 0.170 |
Why?
|
Fatty Acids, Omega-3 | 5 | 1993 | 122 | 0.170 |
Why?
|
Salmonella Infections, Animal | 1 | 2000 | 36 | 0.170 |
Why?
|
Nitric Oxide Synthase Type II | 5 | 2010 | 157 | 0.170 |
Why?
|
Methotrexate | 3 | 2017 | 226 | 0.170 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2021 | 192 | 0.170 |
Why?
|
Peptide Initiation Factors | 2 | 2010 | 17 | 0.170 |
Why?
|
Blood Pressure | 7 | 2018 | 1538 | 0.170 |
Why?
|
Collagen | 7 | 2011 | 415 | 0.170 |
Why?
|
Diabetes Mellitus | 3 | 2013 | 900 | 0.170 |
Why?
|
Neoplasm Proteins | 3 | 2021 | 385 | 0.170 |
Why?
|
Skin Neoplasms | 3 | 2017 | 756 | 0.170 |
Why?
|
Pregnancy, Animal | 1 | 2000 | 52 | 0.170 |
Why?
|
A549 Cells | 1 | 2019 | 51 | 0.170 |
Why?
|
Coronary Vessels | 1 | 2021 | 227 | 0.160 |
Why?
|
Oxidation-Reduction | 6 | 2022 | 923 | 0.160 |
Why?
|
COS Cells | 5 | 2004 | 175 | 0.160 |
Why?
|
Osteogenesis | 2 | 2022 | 183 | 0.160 |
Why?
|
Salmonella typhimurium | 2 | 2002 | 164 | 0.160 |
Why?
|
Thrombin | 5 | 2009 | 139 | 0.160 |
Why?
|
Uterine Diseases | 1 | 1999 | 14 | 0.160 |
Why?
|
Receptors, Prostaglandin E | 1 | 1999 | 6 | 0.160 |
Why?
|
Lipids | 7 | 2018 | 580 | 0.160 |
Why?
|
Myelodysplastic Syndromes | 2 | 2013 | 119 | 0.160 |
Why?
|
Chlamydia Infections | 1 | 2000 | 65 | 0.160 |
Why?
|
Risk | 2 | 2020 | 812 | 0.160 |
Why?
|
Biocompatible Materials | 4 | 1996 | 369 | 0.160 |
Why?
|
Neutropenia | 3 | 1999 | 125 | 0.160 |
Why?
|
Depsipeptides | 1 | 2019 | 13 | 0.160 |
Why?
|
Palmitic Acid | 2 | 2019 | 36 | 0.160 |
Why?
|
Calcium-Binding Proteins | 3 | 2016 | 206 | 0.160 |
Why?
|
Streptococcus pneumoniae | 3 | 2017 | 133 | 0.160 |
Why?
|
Phospholipases A | 2 | 2002 | 101 | 0.160 |
Why?
|
Macrophage-1 Antigen | 3 | 2014 | 33 | 0.160 |
Why?
|
Rats, Sprague-Dawley | 14 | 2018 | 2218 | 0.160 |
Why?
|
Oncogene Proteins, Viral | 3 | 2005 | 20 | 0.160 |
Why?
|
Asthma | 2 | 2021 | 2029 | 0.160 |
Why?
|
Stem Cell Factor | 2 | 1998 | 14 | 0.160 |
Why?
|
Arthritis, Reactive | 1 | 2018 | 8 | 0.160 |
Why?
|
Oxidative Stress | 3 | 2022 | 1076 | 0.160 |
Why?
|
Rats, Inbred Strains | 22 | 1998 | 362 | 0.160 |
Why?
|
Prospective Studies | 14 | 2018 | 6220 | 0.160 |
Why?
|
Binding, Competitive | 13 | 2001 | 193 | 0.150 |
Why?
|
Acrylic Resins | 2 | 1989 | 38 | 0.150 |
Why?
|
Pyrimidines | 1 | 2021 | 376 | 0.150 |
Why?
|
Plasma | 3 | 2015 | 211 | 0.150 |
Why?
|
Mice, Inbred DBA | 4 | 2006 | 174 | 0.150 |
Why?
|
AMP-Activated Protein Kinases | 2 | 2017 | 172 | 0.150 |
Why?
|
Chromatin | 2 | 2014 | 428 | 0.150 |
Why?
|
Hospitals, University | 3 | 2016 | 172 | 0.150 |
Why?
|
Lysine | 2 | 2010 | 242 | 0.150 |
Why?
|
Leishmania infantum | 1 | 2018 | 4 | 0.150 |
Why?
|
Indoles | 3 | 2015 | 304 | 0.150 |
Why?
|
Feeding and Eating Disorders | 2 | 1990 | 103 | 0.150 |
Why?
|
ATP Binding Cassette Transporter 1 | 1 | 2018 | 10 | 0.150 |
Why?
|
Leukemia, Hairy Cell | 1 | 1998 | 6 | 0.150 |
Why?
|
Exanthema | 1 | 2019 | 74 | 0.150 |
Why?
|
Borrelia burgdorferi | 1 | 2018 | 12 | 0.150 |
Why?
|
Protein Structure, Secondary | 2 | 2011 | 325 | 0.150 |
Why?
|
Glutathione | 2 | 2018 | 293 | 0.150 |
Why?
|
Chemokine CCL2 | 6 | 2017 | 105 | 0.150 |
Why?
|
omega-N-Methylarginine | 1 | 1997 | 26 | 0.150 |
Why?
|
Th2 Cells | 3 | 2021 | 154 | 0.150 |
Why?
|
Protective Factors | 1 | 2018 | 87 | 0.150 |
Why?
|
Mice, Inbred Strains | 12 | 2008 | 396 | 0.150 |
Why?
|
Drug Delivery Systems | 2 | 2012 | 296 | 0.150 |
Why?
|
Protein Multimerization | 1 | 2019 | 157 | 0.150 |
Why?
|
Receptors, Interleukin-1 Type II | 5 | 2008 | 6 | 0.150 |
Why?
|
Lipoxygenase Inhibitors | 2 | 1991 | 36 | 0.150 |
Why?
|
DNA, Complementary | 4 | 2007 | 256 | 0.150 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 1995 | 534 | 0.150 |
Why?
|
Klebsiella Infections | 4 | 1995 | 23 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2017 | 398 | 0.150 |
Why?
|
Genetic Variation | 2 | 2021 | 870 | 0.150 |
Why?
|
Lipoproteins | 2 | 2017 | 159 | 0.150 |
Why?
|
Bone Marrow | 4 | 2015 | 244 | 0.150 |
Why?
|
DNA Primers | 8 | 2011 | 510 | 0.140 |
Why?
|
Crystallography, X-Ray | 1 | 2019 | 402 | 0.140 |
Why?
|
Leishmaniasis, Cutaneous | 1 | 2017 | 7 | 0.140 |
Why?
|
Administration, Oral | 5 | 2020 | 728 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 5 | 2020 | 2087 | 0.140 |
Why?
|
Bacteria | 2 | 2022 | 725 | 0.140 |
Why?
|
Unrelated Donors | 1 | 2017 | 37 | 0.140 |
Why?
|
Rotarod Performance Test | 1 | 2017 | 17 | 0.140 |
Why?
|
Adenosine | 2 | 2015 | 203 | 0.140 |
Why?
|
Polymyxin B | 9 | 1996 | 21 | 0.140 |
Why?
|
Vascular Endothelial Growth Factor A | 6 | 2021 | 498 | 0.140 |
Why?
|
Heart | 5 | 2009 | 612 | 0.140 |
Why?
|
Dietary Fats, Unsaturated | 2 | 1993 | 21 | 0.140 |
Why?
|
Immunohistochemistry | 12 | 2016 | 1629 | 0.140 |
Why?
|
Wound Healing | 2 | 2017 | 258 | 0.140 |
Why?
|
CARD Signaling Adaptor Proteins | 3 | 2016 | 17 | 0.140 |
Why?
|
Cell Respiration | 1 | 2017 | 74 | 0.140 |
Why?
|
Programmed Cell Death 1 Receptor | 1 | 2018 | 194 | 0.140 |
Why?
|
Antigen-Antibody Reactions | 1 | 1996 | 50 | 0.140 |
Why?
|
Schistosomiasis mansoni | 3 | 2011 | 19 | 0.140 |
Why?
|
Fumarates | 1 | 2016 | 10 | 0.140 |
Why?
|
Calcium | 9 | 2022 | 1108 | 0.140 |
Why?
|
Immunoglobulins | 4 | 2016 | 143 | 0.140 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2019 | 473 | 0.140 |
Why?
|
Saline Solution, Hypertonic | 1 | 1997 | 53 | 0.140 |
Why?
|
Chemotactic Factors | 4 | 2002 | 50 | 0.140 |
Why?
|
Fibrosis | 6 | 2021 | 453 | 0.140 |
Why?
|
Extracellular Space | 3 | 2015 | 116 | 0.140 |
Why?
|
Respiratory Insufficiency | 1 | 2020 | 290 | 0.140 |
Why?
|
Drosophila | 1 | 2018 | 133 | 0.140 |
Why?
|
Histones | 5 | 2017 | 535 | 0.130 |
Why?
|
Berylliosis | 1 | 2018 | 177 | 0.130 |
Why?
|
Streptococcus | 1 | 2016 | 22 | 0.130 |
Why?
|
Pancreas | 3 | 2012 | 276 | 0.130 |
Why?
|
Klebsiella pneumoniae | 2 | 1995 | 41 | 0.130 |
Why?
|
Cerebral Ventricles | 4 | 1993 | 47 | 0.130 |
Why?
|
Synovitis | 1 | 2016 | 24 | 0.130 |
Why?
|
Peptidoglycan | 3 | 2007 | 25 | 0.130 |
Why?
|
Myoblasts | 1 | 2017 | 76 | 0.130 |
Why?
|
Mice, Inbred ICR | 3 | 2012 | 109 | 0.130 |
Why?
|
Glutamine | 1 | 2016 | 91 | 0.130 |
Why?
|
Gene Expression Profiling | 6 | 2021 | 1518 | 0.130 |
Why?
|
Streptococcus pyogenes | 2 | 2010 | 30 | 0.130 |
Why?
|
Carbamates | 2 | 2015 | 34 | 0.130 |
Why?
|
Injections, Intravenous | 7 | 2020 | 198 | 0.130 |
Why?
|
CD28 Antigens | 2 | 2013 | 47 | 0.130 |
Why?
|
Mannose-Binding Lectins | 1 | 1996 | 13 | 0.130 |
Why?
|
Sugar Phosphates | 1 | 2016 | 2 | 0.130 |
Why?
|
Transcription Factor AP-1 | 2 | 2008 | 80 | 0.130 |
Why?
|
Complement Activation | 5 | 1996 | 340 | 0.130 |
Why?
|
Gene Expression Regulation, Bacterial | 2 | 2003 | 285 | 0.130 |
Why?
|
Kidneys, Artificial | 4 | 1993 | 5 | 0.130 |
Why?
|
Oxidative Phosphorylation | 1 | 2017 | 155 | 0.130 |
Why?
|
Disaccharides | 1 | 2016 | 16 | 0.130 |
Why?
|
Potassium Iodide | 1 | 1995 | 3 | 0.130 |
Why?
|
Burns | 4 | 1995 | 237 | 0.130 |
Why?
|
Caspases | 5 | 2022 | 245 | 0.130 |
Why?
|
Cytosol | 4 | 2009 | 208 | 0.130 |
Why?
|
Helminth Proteins | 2 | 2011 | 19 | 0.130 |
Why?
|
Oseltamivir | 1 | 2016 | 11 | 0.130 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2012 | 1143 | 0.130 |
Why?
|
Immunization, Passive | 3 | 1991 | 73 | 0.130 |
Why?
|
HLA-A Antigens | 1 | 2016 | 49 | 0.130 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 2 | 2007 | 28 | 0.130 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2016 | 30 | 0.130 |
Why?
|
Cachexia | 5 | 1998 | 52 | 0.130 |
Why?
|
Body Constitution | 1 | 1996 | 47 | 0.130 |
Why?
|
Drug Evaluation, Preclinical | 3 | 2015 | 161 | 0.130 |
Why?
|
Cardiovascular System | 1 | 2017 | 125 | 0.130 |
Why?
|
Acetylation | 5 | 2017 | 211 | 0.130 |
Why?
|
Viral Load | 2 | 2015 | 405 | 0.130 |
Why?
|
CD8-Positive T-Lymphocytes | 6 | 2021 | 688 | 0.130 |
Why?
|
Immunologic Deficiency Syndromes | 4 | 1989 | 61 | 0.130 |
Why?
|
Oleic Acid | 1 | 2015 | 30 | 0.130 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2015 | 34 | 0.130 |
Why?
|
Intracellular Membranes | 1 | 1995 | 73 | 0.130 |
Why?
|
Interleukin-13 | 1 | 1996 | 122 | 0.130 |
Why?
|
Linoleic Acid | 1 | 2015 | 37 | 0.130 |
Why?
|
Peptides | 4 | 2009 | 848 | 0.130 |
Why?
|
Cross-Over Studies | 3 | 2015 | 440 | 0.120 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2015 | 61 | 0.120 |
Why?
|
Injections, Intra-Articular | 1 | 2015 | 43 | 0.120 |
Why?
|
Hepatitis C, Chronic | 2 | 2011 | 151 | 0.120 |
Why?
|
Dose-Response Relationship, Immunologic | 8 | 2006 | 75 | 0.120 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2018 | 348 | 0.120 |
Why?
|
Triglycerides | 5 | 2011 | 467 | 0.120 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 338 | 0.120 |
Why?
|
Fasciitis, Necrotizing | 2 | 2006 | 9 | 0.120 |
Why?
|
Infusions, Intravenous | 7 | 2020 | 371 | 0.120 |
Why?
|
Coronavirus Infections | 1 | 2020 | 330 | 0.120 |
Why?
|
Hepatitis, Chronic | 1 | 1995 | 5 | 0.120 |
Why?
|
CD11b Antigen | 3 | 2018 | 57 | 0.120 |
Why?
|
Glucocorticoids | 5 | 2005 | 532 | 0.120 |
Why?
|
Gene-Environment Interaction | 1 | 2016 | 183 | 0.120 |
Why?
|
Glomerulonephritis, Membranoproliferative | 1 | 1995 | 13 | 0.120 |
Why?
|
Labor, Obstetric | 2 | 1992 | 52 | 0.120 |
Why?
|
Fatigue | 1 | 2017 | 294 | 0.120 |
Why?
|
Graft Survival | 2 | 2011 | 446 | 0.120 |
Why?
|
Running | 2 | 2017 | 207 | 0.120 |
Why?
|
Ureteral Obstruction | 2 | 2006 | 54 | 0.120 |
Why?
|
Cardiovascular Agents | 1 | 2016 | 126 | 0.120 |
Why?
|
Hepatitis C | 2 | 1995 | 219 | 0.120 |
Why?
|
Caspase 7 | 1 | 2014 | 20 | 0.120 |
Why?
|
Pulmonary Aspergillosis | 1 | 2014 | 3 | 0.120 |
Why?
|
Disease Susceptibility | 5 | 2021 | 316 | 0.120 |
Why?
|
Physical Conditioning, Animal | 1 | 2017 | 194 | 0.120 |
Why?
|
Silicosis | 1 | 2015 | 21 | 0.120 |
Why?
|
Ozone | 2 | 2007 | 99 | 0.120 |
Why?
|
Cellulitis | 2 | 2006 | 45 | 0.120 |
Why?
|
Interleukin-16 | 2 | 2017 | 6 | 0.120 |
Why?
|
Thymus Gland | 6 | 2005 | 296 | 0.120 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 151 | 0.120 |
Why?
|
Child | 20 | 2016 | 18422 | 0.120 |
Why?
|
Candida | 1 | 2014 | 32 | 0.120 |
Why?
|
Inhibitory Concentration 50 | 1 | 2014 | 74 | 0.120 |
Why?
|
Gene Silencing | 3 | 2011 | 171 | 0.120 |
Why?
|
Neurodegenerative Diseases | 2 | 2019 | 93 | 0.120 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 1994 | 15 | 0.120 |
Why?
|
Blood | 5 | 2016 | 96 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2015 | 117 | 0.120 |
Why?
|
Protein Conformation | 8 | 2009 | 805 | 0.120 |
Why?
|
Graft vs Leukemia Effect | 1 | 2014 | 12 | 0.120 |
Why?
|
Stroke Volume | 2 | 2016 | 504 | 0.120 |
Why?
|
Glomerulonephritis | 1 | 1995 | 45 | 0.120 |
Why?
|
Meningococcal Infections | 2 | 1997 | 20 | 0.120 |
Why?
|
Protease Inhibitors | 1 | 1995 | 97 | 0.120 |
Why?
|
Cisplatin | 2 | 2007 | 262 | 0.120 |
Why?
|
Blotting, Northern | 9 | 1994 | 193 | 0.120 |
Why?
|
Dengue | 1 | 2015 | 59 | 0.120 |
Why?
|
Microbiota | 3 | 2017 | 647 | 0.120 |
Why?
|
Turpentine | 4 | 1998 | 5 | 0.120 |
Why?
|
Schistosoma mansoni | 3 | 2011 | 33 | 0.120 |
Why?
|
Butyrates | 1 | 2015 | 53 | 0.120 |
Why?
|
Fungal Polysaccharides | 1 | 2014 | 1 | 0.120 |
Why?
|
Gene Knockdown Techniques | 2 | 2017 | 301 | 0.120 |
Why?
|
Obstetric Labor Complications | 2 | 1992 | 30 | 0.110 |
Why?
|
Alternative Splicing | 1 | 2015 | 187 | 0.110 |
Why?
|
Ethanol | 2 | 2017 | 538 | 0.110 |
Why?
|
Cardiomegaly | 2 | 2013 | 157 | 0.110 |
Why?
|
Cats | 8 | 1993 | 193 | 0.110 |
Why?
|
Synovial Fluid | 6 | 2009 | 56 | 0.110 |
Why?
|
Necrosis | 6 | 2010 | 211 | 0.110 |
Why?
|
Kidney Diseases | 2 | 2008 | 350 | 0.110 |
Why?
|
Hypoglycemic Agents | 2 | 2012 | 1013 | 0.110 |
Why?
|
Glucans | 1 | 1993 | 25 | 0.110 |
Why?
|
Colon | 6 | 2019 | 233 | 0.110 |
Why?
|
Species Specificity | 9 | 2001 | 542 | 0.110 |
Why?
|
Ischemia | 2 | 2011 | 362 | 0.110 |
Why?
|
Body Composition | 5 | 2018 | 590 | 0.110 |
Why?
|
Oncogenes | 2 | 2021 | 103 | 0.110 |
Why?
|
Parvoviridae Infections | 1 | 2013 | 11 | 0.110 |
Why?
|
Food, Fortified | 1 | 1993 | 36 | 0.110 |
Why?
|
Active Transport, Cell Nucleus | 3 | 2014 | 110 | 0.110 |
Why?
|
Hypertriglyceridemia | 2 | 2010 | 34 | 0.110 |
Why?
|
Autophagy-Related Proteins | 1 | 2013 | 39 | 0.110 |
Why?
|
Polysaccharides | 1 | 2014 | 78 | 0.110 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2020 | 353 | 0.110 |
Why?
|
Superoxides | 6 | 2014 | 214 | 0.110 |
Why?
|
Ligands | 4 | 2015 | 562 | 0.110 |
Why?
|
Bronchial Hyperreactivity | 2 | 2004 | 95 | 0.110 |
Why?
|
Biological Products | 6 | 1988 | 166 | 0.110 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2013 | 3 | 0.110 |
Why?
|
Fetal Blood | 3 | 1990 | 270 | 0.110 |
Why?
|
Mycophenolic Acid | 1 | 2013 | 77 | 0.110 |
Why?
|
Survival Rate | 6 | 2018 | 1644 | 0.110 |
Why?
|
Immunoglobulins, Intravenous | 1 | 1994 | 122 | 0.110 |
Why?
|
Cystic Fibrosis | 2 | 2016 | 955 | 0.110 |
Why?
|
Rheumatic Fever | 1 | 2013 | 7 | 0.110 |
Why?
|
DNA Damage | 1 | 2015 | 351 | 0.110 |
Why?
|
Receptors, Interleukin-2 | 6 | 2010 | 64 | 0.110 |
Why?
|
Microbial Collagenase | 3 | 1990 | 10 | 0.110 |
Why?
|
Ileitis | 1 | 2013 | 26 | 0.110 |
Why?
|
Imidazoles | 6 | 2004 | 208 | 0.110 |
Why?
|
Blood Coagulation | 5 | 2018 | 218 | 0.110 |
Why?
|
Peritoneal Dialysis | 2 | 1985 | 84 | 0.110 |
Why?
|
Cricetulus | 2 | 2013 | 97 | 0.110 |
Why?
|
Bronchoalveolar Lavage Fluid | 5 | 2013 | 590 | 0.110 |
Why?
|
Protein Kinase C | 3 | 1992 | 273 | 0.110 |
Why?
|
Exons | 5 | 2004 | 302 | 0.100 |
Why?
|
Streptococcal Infections | 2 | 2000 | 131 | 0.100 |
Why?
|
Adipocytes | 1 | 2014 | 188 | 0.100 |
Why?
|
Platelet Activating Factor | 4 | 2002 | 90 | 0.100 |
Why?
|
Vaccines, DNA | 2 | 2003 | 29 | 0.100 |
Why?
|
Eicosanoids | 1 | 1993 | 54 | 0.100 |
Why?
|
Cell Count | 7 | 2008 | 303 | 0.100 |
Why?
|
Drug Administration Schedule | 3 | 2010 | 718 | 0.100 |
Why?
|
Oligopeptides | 4 | 2011 | 236 | 0.100 |
Why?
|
Antigens, Helminth | 2 | 2011 | 12 | 0.100 |
Why?
|
Monokines | 9 | 2004 | 24 | 0.100 |
Why?
|
Thromboxane B2 | 3 | 1989 | 26 | 0.100 |
Why?
|
Valproic Acid | 2 | 2010 | 43 | 0.100 |
Why?
|
Insulin-Like Growth Factor I | 3 | 2003 | 286 | 0.100 |
Why?
|
Transgenes | 3 | 2019 | 170 | 0.100 |
Why?
|
Histone Deacetylase 1 | 1 | 2012 | 16 | 0.100 |
Why?
|
Colchicine | 4 | 1995 | 24 | 0.100 |
Why?
|
Sequence Deletion | 3 | 2004 | 167 | 0.100 |
Why?
|
alpha 1-Antitrypsin Deficiency | 2 | 2013 | 70 | 0.100 |
Why?
|
Mycobacterium Infections | 1 | 2013 | 61 | 0.100 |
Why?
|
Extracellular Matrix Proteins | 3 | 2021 | 127 | 0.100 |
Why?
|
Granulocytes | 3 | 2005 | 77 | 0.100 |
Why?
|
Virus Latency | 1 | 2013 | 80 | 0.100 |
Why?
|
Mutagenesis, Site-Directed | 3 | 2014 | 345 | 0.100 |
Why?
|
Chemokine CCL4 | 2 | 2005 | 21 | 0.100 |
Why?
|
Tissue Donors | 1 | 2014 | 316 | 0.100 |
Why?
|
Blood Vessels | 3 | 1992 | 180 | 0.100 |
Why?
|
Methylcholanthrene | 2 | 2009 | 18 | 0.100 |
Why?
|
Heart Failure, Systolic | 1 | 2012 | 20 | 0.100 |
Why?
|
Reagent Kits, Diagnostic | 1 | 1992 | 42 | 0.100 |
Why?
|
Antigens, Fungal | 1 | 2012 | 24 | 0.100 |
Why?
|
Cell Separation | 11 | 1997 | 291 | 0.100 |
Why?
|
Adrenocorticotropic Hormone | 5 | 1994 | 128 | 0.100 |
Why?
|
Thiadiazines | 1 | 1991 | 2 | 0.100 |
Why?
|
Adiponectin | 3 | 2014 | 213 | 0.100 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2011 | 27 | 0.100 |
Why?
|
Sequence Alignment | 2 | 2005 | 323 | 0.100 |
Why?
|
Antigens, Bacterial | 3 | 2010 | 112 | 0.100 |
Why?
|
Chemokines, CXC | 2 | 2002 | 60 | 0.100 |
Why?
|
Cartilage | 3 | 1990 | 182 | 0.100 |
Why?
|
Genomics | 1 | 2016 | 635 | 0.100 |
Why?
|
Ultrasonography | 2 | 2017 | 634 | 0.100 |
Why?
|
Clinical Trials, Phase II as Topic | 2 | 2020 | 59 | 0.100 |
Why?
|
Physical Exertion | 3 | 1989 | 209 | 0.100 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 668 | 0.100 |
Why?
|
Focal Adhesions | 1 | 2011 | 42 | 0.100 |
Why?
|
Genetic Engineering | 2 | 2010 | 80 | 0.100 |
Why?
|
Cell Membrane | 4 | 2007 | 680 | 0.100 |
Why?
|
Colitis, Ulcerative | 3 | 2005 | 105 | 0.100 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2011 | 32 | 0.100 |
Why?
|
Hearing Loss | 1 | 2014 | 183 | 0.090 |
Why?
|
Phenols | 2 | 1995 | 82 | 0.090 |
Why?
|
Risk Factors | 8 | 2017 | 8634 | 0.090 |
Why?
|
Pneumonia, Bacterial | 2 | 2003 | 106 | 0.090 |
Why?
|
Phenotype | 4 | 2016 | 2797 | 0.090 |
Why?
|
Peroxidase | 6 | 2005 | 163 | 0.090 |
Why?
|
Drug Contamination | 3 | 1998 | 52 | 0.090 |
Why?
|
Acquired Immunodeficiency Syndrome | 5 | 1996 | 217 | 0.090 |
Why?
|
Taurine | 1 | 1991 | 41 | 0.090 |
Why?
|
Neoplastic Stem Cells | 1 | 1995 | 329 | 0.090 |
Why?
|
Isoproterenol | 1 | 2011 | 106 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2016 | 486 | 0.090 |
Why?
|
Placebos | 5 | 2020 | 197 | 0.090 |
Why?
|
Carcinoma, Renal Cell | 4 | 1999 | 168 | 0.090 |
Why?
|
Aorta | 2 | 2013 | 386 | 0.090 |
Why?
|
Vesicular stomatitis Indiana virus | 1 | 2011 | 13 | 0.090 |
Why?
|
Intention to Treat Analysis | 1 | 2011 | 68 | 0.090 |
Why?
|
Cell Migration Inhibition | 2 | 2009 | 13 | 0.090 |
Why?
|
Drug Tolerance | 5 | 2020 | 79 | 0.090 |
Why?
|
Antioxidants | 1 | 2015 | 530 | 0.090 |
Why?
|
Diabetes Mellitus, Experimental | 3 | 2013 | 160 | 0.090 |
Why?
|
G1 Phase | 1 | 1991 | 68 | 0.090 |
Why?
|
Nasal Polyps | 1 | 2011 | 49 | 0.090 |
Why?
|
Triggering Receptor Expressed on Myeloid Cells-1 | 2 | 2011 | 6 | 0.090 |
Why?
|
Herpesvirus 2, Human | 1 | 2011 | 27 | 0.090 |
Why?
|
MicroRNAs | 1 | 2017 | 600 | 0.090 |
Why?
|
In Situ Nick-End Labeling | 4 | 2016 | 119 | 0.090 |
Why?
|
Muscle Development | 2 | 2017 | 98 | 0.090 |
Why?
|
Mice, Nude | 5 | 2017 | 630 | 0.090 |
Why?
|
Bone Marrow Cells | 7 | 2008 | 267 | 0.090 |
Why?
|
Mycobacterium avium Complex | 1 | 2011 | 92 | 0.090 |
Why?
|
Antigens, Differentiation | 4 | 2010 | 79 | 0.090 |
Why?
|
Papillomaviridae | 2 | 2001 | 101 | 0.090 |
Why?
|
Alkynes | 1 | 1991 | 53 | 0.090 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2011 | 63 | 0.090 |
Why?
|
Comorbidity | 1 | 2015 | 1448 | 0.090 |
Why?
|
Injections, Subcutaneous | 3 | 2017 | 134 | 0.090 |
Why?
|
Smad3 Protein | 1 | 2010 | 41 | 0.090 |
Why?
|
Sulfonamides | 2 | 2011 | 445 | 0.090 |
Why?
|
Growth Hormone | 2 | 1996 | 103 | 0.090 |
Why?
|
Protein Kinases | 2 | 2009 | 307 | 0.090 |
Why?
|
Capillaries | 2 | 1987 | 91 | 0.090 |
Why?
|
Drug Therapy, Combination | 2 | 2016 | 951 | 0.090 |
Why?
|
Colostrum | 1 | 1990 | 2 | 0.090 |
Why?
|
Creatine Kinase | 4 | 2001 | 75 | 0.090 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 607 | 0.090 |
Why?
|
Immunization | 3 | 2018 | 397 | 0.090 |
Why?
|
Thromboxanes | 2 | 1988 | 14 | 0.090 |
Why?
|
Mice, Inbred NOD | 3 | 2022 | 555 | 0.090 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2012 | 139 | 0.090 |
Why?
|
Rats, Inbred Lew | 5 | 2017 | 91 | 0.090 |
Why?
|
Eosinophils | 3 | 2004 | 278 | 0.090 |
Why?
|
Respiratory System | 1 | 2011 | 137 | 0.090 |
Why?
|
Tobacco Smoke Pollution | 1 | 2013 | 217 | 0.090 |
Why?
|
Sensitivity and Specificity | 5 | 1999 | 1694 | 0.090 |
Why?
|
Pyridines | 5 | 2004 | 425 | 0.090 |
Why?
|
Microscopy, Confocal | 3 | 2014 | 304 | 0.090 |
Why?
|
Hydrocortisone | 6 | 2015 | 267 | 0.090 |
Why?
|
Exercise | 3 | 2013 | 1644 | 0.090 |
Why?
|
Hematologic Neoplasms | 1 | 2011 | 137 | 0.090 |
Why?
|
Virus Diseases | 3 | 2003 | 195 | 0.090 |
Why?
|
Glucagon | 7 | 1996 | 92 | 0.090 |
Why?
|
Tumor Microenvironment | 3 | 2018 | 430 | 0.090 |
Why?
|
Caspase 2 | 1 | 2009 | 14 | 0.090 |
Why?
|
Nerve Growth Factors | 3 | 1995 | 71 | 0.090 |
Why?
|
Rhinitis | 1 | 2011 | 128 | 0.090 |
Why?
|
Kidney Tubules | 3 | 2008 | 107 | 0.090 |
Why?
|
Insulin | 15 | 2014 | 2080 | 0.080 |
Why?
|
6-Ketoprostaglandin F1 alpha | 3 | 1989 | 21 | 0.080 |
Why?
|
Delivery, Obstetric | 1 | 1990 | 118 | 0.080 |
Why?
|
Lymphocyte Culture Test, Mixed | 4 | 2006 | 41 | 0.080 |
Why?
|
Blood Glucose | 9 | 2018 | 1829 | 0.080 |
Why?
|
Electrophoresis | 2 | 2000 | 26 | 0.080 |
Why?
|
Microspheres | 2 | 2007 | 123 | 0.080 |
Why?
|
Suppressor of Cytokine Signaling 3 Protein | 1 | 2009 | 7 | 0.080 |
Why?
|
Models, Animal | 2 | 2018 | 344 | 0.080 |
Why?
|
Angiogenic Proteins | 1 | 2009 | 18 | 0.080 |
Why?
|
Transcription Factors | 5 | 2014 | 1528 | 0.080 |
Why?
|
Complement System Proteins | 2 | 1990 | 283 | 0.080 |
Why?
|
CD3 Complex | 4 | 2002 | 92 | 0.080 |
Why?
|
Endopeptidases | 2 | 1987 | 71 | 0.080 |
Why?
|
Lysosomes | 4 | 2006 | 123 | 0.080 |
Why?
|
Plasmapheresis | 1 | 1989 | 22 | 0.080 |
Why?
|
Immunocompetence | 2 | 1987 | 40 | 0.080 |
Why?
|
Rats, Inbred BN | 1 | 2009 | 52 | 0.080 |
Why?
|
Sinusitis | 1 | 2011 | 174 | 0.080 |
Why?
|
History, 21st Century | 1 | 2010 | 159 | 0.080 |
Why?
|
Liposomes | 2 | 2008 | 146 | 0.080 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2009 | 37 | 0.080 |
Why?
|
Computational Biology | 2 | 2011 | 530 | 0.080 |
Why?
|
Hyperthermia, Induced | 1 | 1990 | 65 | 0.080 |
Why?
|
Thrombomodulin | 1 | 2009 | 7 | 0.080 |
Why?
|
Mitogens | 3 | 2006 | 58 | 0.080 |
Why?
|
Pregnancy | 9 | 2000 | 5520 | 0.080 |
Why?
|
Acrylonitrile | 1 | 1989 | 1 | 0.080 |
Why?
|
Immunophenotyping | 3 | 2021 | 274 | 0.080 |
Why?
|
Ultraviolet Therapy | 1 | 1989 | 16 | 0.080 |
Why?
|
Carcinoma | 1 | 2010 | 198 | 0.080 |
Why?
|
Peritoneal Cavity | 3 | 1998 | 23 | 0.080 |
Why?
|
Receptors, Purinergic P2 | 1 | 2009 | 20 | 0.080 |
Why?
|
Neoplasm Transplantation | 4 | 2017 | 228 | 0.080 |
Why?
|
Staphylococcus | 6 | 2003 | 69 | 0.080 |
Why?
|
I-kappa B Kinase | 1 | 2009 | 50 | 0.080 |
Why?
|
Superoxide Dismutase | 3 | 2008 | 306 | 0.080 |
Why?
|
Fluorescein Angiography | 1 | 2009 | 102 | 0.080 |
Why?
|
Dextrans | 1 | 2009 | 73 | 0.080 |
Why?
|
Phagocytes | 4 | 1984 | 90 | 0.080 |
Why?
|
Fatty Liver | 1 | 2011 | 211 | 0.080 |
Why?
|
Isoelectric Focusing | 7 | 1991 | 33 | 0.080 |
Why?
|
Glycerides | 1 | 1988 | 14 | 0.080 |
Why?
|
Injections | 1 | 2009 | 159 | 0.080 |
Why?
|
Bone Resorption | 2 | 1996 | 73 | 0.080 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 5 | 1991 | 318 | 0.080 |
Why?
|
Neuroglia | 1 | 2009 | 150 | 0.080 |
Why?
|
Point Mutation | 3 | 2021 | 216 | 0.080 |
Why?
|
Drug Carriers | 2 | 2007 | 112 | 0.080 |
Why?
|
Kidney Neoplasms | 3 | 1999 | 327 | 0.080 |
Why?
|
Vitreous Body | 1 | 2009 | 101 | 0.080 |
Why?
|
Mesoderm | 1 | 2009 | 138 | 0.080 |
Why?
|
Recurrence | 3 | 2017 | 935 | 0.080 |
Why?
|
Human Umbilical Vein Endothelial Cells | 3 | 2013 | 89 | 0.080 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2008 | 2 | 0.080 |
Why?
|
Immunoblotting | 5 | 2010 | 283 | 0.080 |
Why?
|
Growth Inhibitors | 2 | 1996 | 43 | 0.080 |
Why?
|
Diglycerides | 1 | 1988 | 53 | 0.080 |
Why?
|
Multiple Sclerosis | 2 | 1990 | 376 | 0.080 |
Why?
|
Retrospective Studies | 5 | 2022 | 12556 | 0.080 |
Why?
|
Neovascularization, Physiologic | 1 | 2009 | 173 | 0.070 |
Why?
|
Matrix Metalloproteinase 9 | 3 | 2013 | 119 | 0.070 |
Why?
|
Granulomatosis with Polyangiitis | 1 | 2008 | 41 | 0.070 |
Why?
|
Lipoproteins, LDL | 2 | 2016 | 128 | 0.070 |
Why?
|
Enzyme Induction | 1 | 2008 | 84 | 0.070 |
Why?
|
Ciliary Neurotrophic Factor | 4 | 1996 | 8 | 0.070 |
Why?
|
Cell Survival | 8 | 2012 | 1021 | 0.070 |
Why?
|
RNA | 5 | 2008 | 809 | 0.070 |
Why?
|
Osmotic Pressure | 2 | 1998 | 28 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 5 | 2016 | 397 | 0.070 |
Why?
|
Poly I-C | 2 | 2018 | 51 | 0.070 |
Why?
|
Platelet Count | 4 | 2018 | 81 | 0.070 |
Why?
|
3T3-L1 Cells | 1 | 2007 | 31 | 0.070 |
Why?
|
Prednisone | 1 | 2008 | 229 | 0.070 |
Why?
|
Plasminogen Inactivators | 2 | 1987 | 3 | 0.070 |
Why?
|
Polyglycolic Acid | 1 | 2007 | 43 | 0.070 |
Why?
|
Stomach Neoplasms | 1 | 2008 | 65 | 0.070 |
Why?
|
Teichoic Acids | 2 | 2001 | 12 | 0.070 |
Why?
|
Pancreatitis | 1 | 2008 | 107 | 0.070 |
Why?
|
Animals, Newborn | 4 | 2010 | 778 | 0.070 |
Why?
|
Flavonoids | 2 | 2004 | 66 | 0.070 |
Why?
|
Infant, Newborn | 6 | 1994 | 5047 | 0.070 |
Why?
|
Anticarcinogenic Agents | 1 | 2008 | 67 | 0.070 |
Why?
|
Cocarcinogenesis | 1 | 2007 | 14 | 0.070 |
Why?
|
Antigens, Surface | 5 | 1992 | 146 | 0.070 |
Why?
|
Purinergic P2 Receptor Antagonists | 1 | 2007 | 5 | 0.070 |
Why?
|
Chromatography, Gel | 11 | 1999 | 122 | 0.070 |
Why?
|
Skin Diseases, Infectious | 1 | 1987 | 15 | 0.070 |
Why?
|
Etanercept | 2 | 2005 | 51 | 0.070 |
Why?
|
NF-KappaB Inhibitor alpha | 3 | 2002 | 52 | 0.070 |
Why?
|
Melanocyte-Stimulating Hormones | 1 | 1986 | 2 | 0.070 |
Why?
|
Parathyroid Hormone | 1 | 1987 | 96 | 0.070 |
Why?
|
Angina, Unstable | 2 | 2014 | 72 | 0.070 |
Why?
|
Polyethylene Glycols | 4 | 2006 | 561 | 0.070 |
Why?
|
Macromolecular Substances | 2 | 2004 | 200 | 0.070 |
Why?
|
Blood Sedimentation | 2 | 2019 | 32 | 0.070 |
Why?
|
Culture Media, Conditioned | 3 | 2010 | 105 | 0.070 |
Why?
|
Remission, Spontaneous | 1 | 2006 | 37 | 0.070 |
Why?
|
Interferon Regulatory Factor-1 | 5 | 2007 | 14 | 0.070 |
Why?
|
Cytomegalovirus Infections | 1 | 1989 | 180 | 0.070 |
Why?
|
Cell Degranulation | 1 | 2006 | 39 | 0.070 |
Why?
|
Fish Oils | 3 | 1998 | 21 | 0.070 |
Why?
|
Allergens | 2 | 2021 | 413 | 0.070 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2006 | 3 | 0.070 |
Why?
|
Isoelectric Point | 6 | 1990 | 22 | 0.070 |
Why?
|
Plasminogen Activators | 1 | 1986 | 7 | 0.070 |
Why?
|
Linkage Disequilibrium | 3 | 2008 | 245 | 0.070 |
Why?
|
Neuroprotective Agents | 2 | 2009 | 104 | 0.070 |
Why?
|
Arachidonic Acids | 2 | 1984 | 56 | 0.070 |
Why?
|
Crosses, Genetic | 1 | 2006 | 139 | 0.070 |
Why?
|
Antibody Formation | 3 | 1996 | 266 | 0.070 |
Why?
|
Hydrolysis | 2 | 2002 | 173 | 0.070 |
Why?
|
Astrocytoma | 1 | 1987 | 108 | 0.070 |
Why?
|
Hyperphagia | 1 | 2006 | 28 | 0.070 |
Why?
|
Influenza, Human | 1 | 2012 | 546 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 439 | 0.070 |
Why?
|
Treatment Failure | 2 | 2017 | 331 | 0.070 |
Why?
|
HMGB1 Protein | 2 | 2017 | 48 | 0.070 |
Why?
|
Kidney Tubules, Proximal | 1 | 2007 | 113 | 0.070 |
Why?
|
Injections, Intraventricular | 4 | 1993 | 71 | 0.070 |
Why?
|
Bacterial Load | 2 | 2017 | 58 | 0.070 |
Why?
|
Coronary Disease | 3 | 1999 | 348 | 0.060 |
Why?
|
Cyclic AMP | 5 | 1991 | 227 | 0.060 |
Why?
|
PTEN Phosphohydrolase | 2 | 2019 | 140 | 0.060 |
Why?
|
Receptors, Chemokine | 1 | 2005 | 44 | 0.060 |
Why?
|
Genes, Viral | 1 | 2006 | 89 | 0.060 |
Why?
|
Clinical Trials as Topic | 5 | 2015 | 932 | 0.060 |
Why?
|
Lactic Acid | 1 | 2007 | 275 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 2008 | 215 | 0.060 |
Why?
|
Leishmaniasis | 1 | 1985 | 1 | 0.060 |
Why?
|
Body Fluids | 2 | 2001 | 58 | 0.060 |
Why?
|
Chemokine CCL5 | 2 | 2013 | 45 | 0.060 |
Why?
|
Chemokine CCL3 | 1 | 2005 | 15 | 0.060 |
Why?
|
Fas Ligand Protein | 2 | 2004 | 57 | 0.060 |
Why?
|
Carcinoma, Hepatocellular | 5 | 2011 | 211 | 0.060 |
Why?
|
Lung Neoplasms | 3 | 2008 | 2177 | 0.060 |
Why?
|
Osmolar Concentration | 4 | 1998 | 173 | 0.060 |
Why?
|
Gram-Negative Bacteria | 2 | 2022 | 66 | 0.060 |
Why?
|
Iodine Radioisotopes | 3 | 2013 | 125 | 0.060 |
Why?
|
Proteolysis | 2 | 2016 | 142 | 0.060 |
Why?
|
Pancreatic Elastase | 3 | 2015 | 66 | 0.060 |
Why?
|
Dermatitis | 1 | 2005 | 17 | 0.060 |
Why?
|
Hodgkin Disease | 1 | 1987 | 121 | 0.060 |
Why?
|
Child, Preschool | 10 | 2016 | 9119 | 0.060 |
Why?
|
Disease-Free Survival | 2 | 2018 | 620 | 0.060 |
Why?
|
NLR Proteins | 2 | 2017 | 6 | 0.060 |
Why?
|
Hypothalamus, Anterior | 1 | 1985 | 2 | 0.060 |
Why?
|
Genetic Vectors | 2 | 2010 | 289 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2013 | 916 | 0.060 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 2004 | 152 | 0.060 |
Why?
|
Analgesics, Non-Narcotic | 2 | 1997 | 120 | 0.060 |
Why?
|
Demography | 2 | 2017 | 260 | 0.060 |
Why?
|
Abscess | 1 | 2006 | 72 | 0.060 |
Why?
|
Antimetabolites | 1 | 1985 | 21 | 0.060 |
Why?
|
HeLa Cells | 3 | 2017 | 562 | 0.060 |
Why?
|
Transforming Growth Factor beta1 | 3 | 2013 | 153 | 0.060 |
Why?
|
Dermatitis, Contact | 2 | 2014 | 23 | 0.060 |
Why?
|
Oxygen Consumption | 5 | 2014 | 588 | 0.060 |
Why?
|
Luteal Phase | 1 | 1985 | 41 | 0.060 |
Why?
|
Bacterial Proteins | 3 | 2022 | 736 | 0.060 |
Why?
|
Cytoplasm | 5 | 2015 | 255 | 0.060 |
Why?
|
Sleep | 6 | 1989 | 632 | 0.060 |
Why?
|
Receptors, Interferon | 5 | 2008 | 47 | 0.060 |
Why?
|
Microarray Analysis | 1 | 2005 | 118 | 0.060 |
Why?
|
Cycloheximide | 4 | 1990 | 54 | 0.060 |
Why?
|
Infliximab | 1 | 2005 | 94 | 0.060 |
Why?
|
Insulin Antagonists | 1 | 1984 | 6 | 0.060 |
Why?
|
Chemical Phenomena | 4 | 1987 | 80 | 0.060 |
Why?
|
Precipitin Tests | 2 | 1996 | 88 | 0.060 |
Why?
|
Cyclosporins | 1 | 1984 | 58 | 0.060 |
Why?
|
Rats, Wistar | 4 | 2012 | 368 | 0.060 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 3 | 2013 | 84 | 0.060 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 2 | 2015 | 53 | 0.060 |
Why?
|
Proteoglycans | 4 | 2009 | 107 | 0.060 |
Why?
|
Intubation, Intratracheal | 1 | 2006 | 216 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2004 | 97 | 0.060 |
Why?
|
Dialysis Solutions | 2 | 1998 | 21 | 0.060 |
Why?
|
Leukemia | 3 | 2004 | 209 | 0.060 |
Why?
|
Wounds and Injuries | 4 | 2000 | 749 | 0.060 |
Why?
|
Deltaretrovirus Infections | 3 | 1988 | 6 | 0.060 |
Why?
|
Adenosine Diphosphate | 2 | 2015 | 81 | 0.060 |
Why?
|
Prognosis | 5 | 2017 | 3330 | 0.060 |
Why?
|
ADP Ribose Transferases | 2 | 2002 | 9 | 0.060 |
Why?
|
Body Mass Index | 4 | 2016 | 1959 | 0.060 |
Why?
|
Heart Atria | 2 | 2001 | 107 | 0.060 |
Why?
|
Complement C5 | 3 | 1988 | 73 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2005 | 309 | 0.060 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2016 | 249 | 0.060 |
Why?
|
Cell Transplantation | 1 | 2003 | 36 | 0.060 |
Why?
|
Catecholamines | 2 | 2010 | 94 | 0.060 |
Why?
|
Conserved Sequence | 1 | 2004 | 218 | 0.060 |
Why?
|
Epinephrine | 3 | 1993 | 164 | 0.060 |
Why?
|
Neoplasm Invasiveness | 4 | 2007 | 442 | 0.050 |
Why?
|
Restriction Mapping | 3 | 2004 | 77 | 0.050 |
Why?
|
Antibody-Producing Cells | 1 | 1983 | 29 | 0.050 |
Why?
|
Models, Molecular | 3 | 2011 | 1369 | 0.050 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2003 | 37 | 0.050 |
Why?
|
Electrophoretic Mobility Shift Assay | 3 | 2011 | 72 | 0.050 |
Why?
|
Glycosylation | 3 | 1992 | 130 | 0.050 |
Why?
|
Cyclophosphamide | 3 | 1994 | 217 | 0.050 |
Why?
|
Entamoeba histolytica | 1 | 2003 | 7 | 0.050 |
Why?
|
Immunocompromised Host | 1 | 2005 | 195 | 0.050 |
Why?
|
Antigens, Ly | 2 | 2015 | 45 | 0.050 |
Why?
|
Brain Chemistry | 2 | 1994 | 115 | 0.050 |
Why?
|
Metalloendopeptidases | 3 | 1995 | 55 | 0.050 |
Why?
|
Specific Pathogen-Free Organisms | 3 | 2010 | 59 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2012 | 740 | 0.050 |
Why?
|
Pain | 1 | 1988 | 705 | 0.050 |
Why?
|
Cimetidine | 2 | 1994 | 11 | 0.050 |
Why?
|
Fasting | 2 | 1999 | 241 | 0.050 |
Why?
|
Chemokine CXCL2 | 4 | 2004 | 41 | 0.050 |
Why?
|
Stimulation, Chemical | 8 | 1989 | 56 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2005 | 388 | 0.050 |
Why?
|
Integrin alphaVbeta3 | 2 | 2013 | 20 | 0.050 |
Why?
|
Endothelial Growth Factors | 1 | 2003 | 50 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2013 | 86 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 2 | 2013 | 66 | 0.050 |
Why?
|
Substrate Specificity | 3 | 2003 | 352 | 0.050 |
Why?
|
Forkhead Transcription Factors | 2 | 2014 | 170 | 0.050 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2003 | 61 | 0.050 |
Why?
|
Receptors, Interleukin-9 | 1 | 2022 | 2 | 0.050 |
Why?
|
Adrenal Cortex Hormones | 3 | 1995 | 497 | 0.050 |
Why?
|
Matrilin Proteins | 1 | 2022 | 7 | 0.050 |
Why?
|
Protozoan Proteins | 1 | 2003 | 62 | 0.050 |
Why?
|
Salmonella Infections | 1 | 2003 | 50 | 0.050 |
Why?
|
CD4 Antigens | 2 | 2005 | 123 | 0.050 |
Why?
|
Bone Morphogenetic Protein 2 | 2 | 2017 | 75 | 0.050 |
Why?
|
Egtazic Acid | 1 | 2002 | 44 | 0.050 |
Why?
|
Virulence | 2 | 2015 | 227 | 0.050 |
Why?
|
Interleukin-11 | 2 | 1999 | 9 | 0.050 |
Why?
|
Actins | 3 | 2009 | 381 | 0.050 |
Why?
|
Head Injuries, Closed | 1 | 2002 | 49 | 0.050 |
Why?
|
Lung Diseases | 1 | 2008 | 701 | 0.050 |
Why?
|
Longevity | 1 | 2003 | 137 | 0.050 |
Why?
|
Salmonella | 2 | 2001 | 54 | 0.050 |
Why?
|
Glycopeptides | 2 | 1980 | 43 | 0.050 |
Why?
|
Polymorphism, Restriction Fragment Length | 3 | 2000 | 65 | 0.050 |
Why?
|
Megakaryocytes | 2 | 1992 | 30 | 0.050 |
Why?
|
Hypoglycemia | 2 | 1998 | 387 | 0.050 |
Why?
|
Genes | 3 | 1987 | 223 | 0.050 |
Why?
|
Cross-Linking Reagents | 2 | 1993 | 181 | 0.050 |
Why?
|
Chemotaxis | 2 | 2014 | 130 | 0.050 |
Why?
|
Cholesterol | 3 | 2016 | 367 | 0.050 |
Why?
|
Virginia | 2 | 2013 | 51 | 0.050 |
Why?
|
Uveitis | 2 | 2013 | 115 | 0.050 |
Why?
|
Amino Acids | 6 | 1994 | 448 | 0.050 |
Why?
|
DNA, Recombinant | 3 | 1986 | 41 | 0.050 |
Why?
|
Depression, Chemical | 2 | 1998 | 22 | 0.050 |
Why?
|
Caspase 8 | 2 | 2015 | 43 | 0.050 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2021 | 30 | 0.050 |
Why?
|
Cell Cycle | 4 | 1998 | 542 | 0.050 |
Why?
|
Mice, Inbred CBA | 3 | 2011 | 49 | 0.050 |
Why?
|
Calcitriol | 2 | 1993 | 53 | 0.050 |
Why?
|
Parenteral Nutrition | 2 | 1994 | 96 | 0.050 |
Why?
|
Microcirculation | 3 | 2003 | 135 | 0.050 |
Why?
|
Mutagenesis | 1 | 2002 | 168 | 0.050 |
Why?
|
Phosphatidylcholines | 2 | 1995 | 133 | 0.050 |
Why?
|
Statistics, Nonparametric | 2 | 2014 | 385 | 0.050 |
Why?
|
Antigen-Antibody Complex | 3 | 1990 | 84 | 0.050 |
Why?
|
Factor Xa | 1 | 2001 | 32 | 0.050 |
Why?
|
Blood Specimen Collection | 2 | 1993 | 31 | 0.050 |
Why?
|
CD56 Antigen | 2 | 2008 | 34 | 0.050 |
Why?
|
Creatinine | 3 | 2008 | 425 | 0.050 |
Why?
|
L-Lactate Dehydrogenase | 3 | 2011 | 107 | 0.050 |
Why?
|
Prevalence | 2 | 2017 | 2251 | 0.050 |
Why?
|
Bacteremia | 2 | 1993 | 160 | 0.050 |
Why?
|
Colony-Forming Units Assay | 3 | 1990 | 88 | 0.050 |
Why?
|
Behavior Observation Techniques | 1 | 2020 | 9 | 0.050 |
Why?
|
Blood Bactericidal Activity | 2 | 1993 | 36 | 0.050 |
Why?
|
Cerebral Cortex | 2 | 2020 | 380 | 0.050 |
Why?
|
Systems Biology | 1 | 2021 | 54 | 0.050 |
Why?
|
Presenilin-1 | 1 | 2020 | 27 | 0.050 |
Why?
|
Leukotriene B4 | 2 | 1991 | 48 | 0.050 |
Why?
|
Spatial Memory | 1 | 2020 | 17 | 0.050 |
Why?
|
Chemistry | 3 | 1987 | 38 | 0.050 |
Why?
|
Mice, Obese | 3 | 2008 | 53 | 0.040 |
Why?
|
Stem Cell Transplantation | 1 | 2001 | 149 | 0.040 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2020 | 54 | 0.040 |
Why?
|
Mammals | 1 | 2022 | 244 | 0.040 |
Why?
|
Arginine | 2 | 1997 | 238 | 0.040 |
Why?
|
CD5 Antigens | 1 | 2000 | 8 | 0.040 |
Why?
|
Arteritis | 1 | 2000 | 27 | 0.040 |
Why?
|
Healthy Volunteers | 1 | 2021 | 197 | 0.040 |
Why?
|
Hematopoietic Cell Growth Factors | 2 | 1992 | 4 | 0.040 |
Why?
|
Staphylococcal Infections | 3 | 1994 | 340 | 0.040 |
Why?
|
Coculture Techniques | 3 | 2005 | 201 | 0.040 |
Why?
|
Arthritis, Infectious | 1 | 2000 | 49 | 0.040 |
Why?
|
Cell Culture Techniques | 2 | 2007 | 343 | 0.040 |
Why?
|
Linear Models | 2 | 2003 | 768 | 0.040 |
Why?
|
Lymphocyte Count | 2 | 2014 | 133 | 0.040 |
Why?
|
Half-Life | 2 | 2006 | 141 | 0.040 |
Why?
|
Fibronectins | 2 | 2002 | 108 | 0.040 |
Why?
|
Transcription Factor RelA | 1 | 2000 | 82 | 0.040 |
Why?
|
Organ Specificity | 5 | 2003 | 268 | 0.040 |
Why?
|
Microscopy, Fluorescence | 3 | 2009 | 396 | 0.040 |
Why?
|
Peroxidases | 1 | 1999 | 25 | 0.040 |
Why?
|
Interleukin-3 | 3 | 1992 | 23 | 0.040 |
Why?
|
Ascitic Fluid | 2 | 1998 | 13 | 0.040 |
Why?
|
Phosphodiesterase Inhibitors | 3 | 1995 | 82 | 0.040 |
Why?
|
Alkaline Phosphatase | 2 | 2017 | 143 | 0.040 |
Why?
|
Chloramphenicol O-Acetyltransferase | 2 | 1996 | 38 | 0.040 |
Why?
|
Massachusetts | 3 | 2003 | 134 | 0.040 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2013 | 103 | 0.040 |
Why?
|
Biological Transport | 2 | 1998 | 374 | 0.040 |
Why?
|
Ferritins | 1 | 2019 | 52 | 0.040 |
Why?
|
Ischemic Preconditioning, Myocardial | 1 | 1998 | 29 | 0.040 |
Why?
|
Microscopy, Electron | 3 | 1990 | 410 | 0.040 |
Why?
|
Neuronal Plasticity | 1 | 2020 | 209 | 0.040 |
Why?
|
Oligonucleotide Probes | 1 | 1998 | 54 | 0.040 |
Why?
|
Infant | 4 | 2016 | 7964 | 0.040 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 2 | 2011 | 34 | 0.040 |
Why?
|
Granzymes | 1 | 2018 | 40 | 0.040 |
Why?
|
Orthomyxoviridae | 2 | 2016 | 35 | 0.040 |
Why?
|
Cell Compartmentation | 2 | 1991 | 51 | 0.040 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2018 | 34 | 0.040 |
Why?
|
Uterus | 1 | 2000 | 192 | 0.040 |
Why?
|
Chemical and Drug Induced Liver Injury | 1 | 2000 | 125 | 0.040 |
Why?
|
HIV Seropositivity | 2 | 1996 | 109 | 0.040 |
Why?
|
Safety | 1 | 2020 | 298 | 0.040 |
Why?
|
Cross-Sectional Studies | 5 | 2015 | 4410 | 0.040 |
Why?
|
Remission Induction | 1 | 2019 | 233 | 0.040 |
Why?
|
Progesterone | 1 | 2000 | 232 | 0.040 |
Why?
|
Dog Diseases | 1 | 1998 | 41 | 0.040 |
Why?
|
2-Chloroadenosine | 1 | 1998 | 3 | 0.040 |
Why?
|
Deoxyadenosines | 1 | 1998 | 7 | 0.040 |
Why?
|
Patient Reported Outcome Measures | 1 | 2020 | 250 | 0.040 |
Why?
|
Liver X Receptors | 1 | 2018 | 30 | 0.040 |
Why?
|
THP-1 Cells | 1 | 2018 | 19 | 0.040 |
Why?
|
Apolipoprotein A-I | 1 | 2018 | 25 | 0.040 |
Why?
|
Connectin | 1 | 2018 | 30 | 0.040 |
Why?
|
Hep G2 Cells | 1 | 2018 | 60 | 0.040 |
Why?
|
Erythrocytes | 3 | 1993 | 591 | 0.040 |
Why?
|
Immunoprecipitation | 2 | 2009 | 151 | 0.040 |
Why?
|
Oxidants | 1 | 1998 | 112 | 0.040 |
Why?
|
Sex Factors | 3 | 2016 | 1715 | 0.040 |
Why?
|
Plastics | 1 | 1998 | 35 | 0.040 |
Why?
|
Irritants | 1 | 1998 | 41 | 0.040 |
Why?
|
Exocytosis | 3 | 2006 | 89 | 0.040 |
Why?
|
Carotid Artery Diseases | 1 | 2018 | 57 | 0.040 |
Why?
|
Freezing | 2 | 1988 | 84 | 0.040 |
Why?
|
Age Factors | 4 | 2016 | 2894 | 0.040 |
Why?
|
Biomarkers, Tumor | 2 | 2019 | 1040 | 0.040 |
Why?
|
Lipolysis | 3 | 1992 | 39 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2001 | 445 | 0.040 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 1998 | 81 | 0.040 |
Why?
|
GTP Phosphohydrolases | 1 | 1997 | 65 | 0.040 |
Why?
|
Myosins | 1 | 2018 | 126 | 0.040 |
Why?
|
Bacteriolysis | 1 | 2017 | 9 | 0.040 |
Why?
|
Lectins | 3 | 1992 | 42 | 0.040 |
Why?
|
fas Receptor | 1 | 1998 | 91 | 0.040 |
Why?
|
Pulmonary Circulation | 1 | 1999 | 407 | 0.040 |
Why?
|
Behavior, Animal | 1 | 2020 | 458 | 0.040 |
Why?
|
Receptors, LDL | 1 | 2017 | 38 | 0.040 |
Why?
|
Cell Hypoxia | 2 | 2010 | 221 | 0.040 |
Why?
|
Mononuclear Phagocyte System | 4 | 1995 | 12 | 0.040 |
Why?
|
Joints | 2 | 2009 | 84 | 0.040 |
Why?
|
Urate Oxidase | 1 | 2017 | 9 | 0.040 |
Why?
|
Vascular Resistance | 2 | 1989 | 337 | 0.040 |
Why?
|
Administration, Intravenous | 1 | 2018 | 124 | 0.040 |
Why?
|
Pancrelipase | 1 | 2017 | 6 | 0.040 |
Why?
|
Beryllium | 1 | 2018 | 146 | 0.040 |
Why?
|
Lipopeptides | 1 | 2017 | 14 | 0.040 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2017 | 40 | 0.040 |
Why?
|
Acetates | 2 | 1989 | 95 | 0.040 |
Why?
|
RAW 264.7 Cells | 1 | 2017 | 41 | 0.040 |
Why?
|
E-Selectin | 1 | 1997 | 53 | 0.040 |
Why?
|
Receptors, CCR2 | 1 | 2017 | 28 | 0.040 |
Why?
|
Gastrointestinal Diseases | 1 | 2019 | 182 | 0.040 |
Why?
|
beta-Defensins | 1 | 2017 | 18 | 0.040 |
Why?
|
Cathelicidins | 1 | 2017 | 38 | 0.040 |
Why?
|
Hepatitis A Virus Cellular Receptor 1 | 1 | 2017 | 35 | 0.040 |
Why?
|
Hyperuricemia | 1 | 2017 | 43 | 0.030 |
Why?
|
Apolipoproteins | 1 | 1997 | 36 | 0.030 |
Why?
|
Mice, Inbred MRL lpr | 2 | 2009 | 37 | 0.030 |
Why?
|
Langerhans Cells | 2 | 1989 | 11 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 1998 | 288 | 0.030 |
Why?
|
Endoscopy | 1 | 1999 | 246 | 0.030 |
Why?
|
Recovery of Function | 1 | 2020 | 574 | 0.030 |
Why?
|
Weight Lifting | 1 | 1996 | 29 | 0.030 |
Why?
|
Pentose Phosphate Pathway | 1 | 2016 | 47 | 0.030 |
Why?
|
Lethal Dose 50 | 1 | 1996 | 12 | 0.030 |
Why?
|
Tissue Survival | 1 | 2016 | 13 | 0.030 |
Why?
|
Blood Cell Count | 1 | 1996 | 50 | 0.030 |
Why?
|
Laminin | 2 | 2009 | 69 | 0.030 |
Why?
|
Simian virus 40 | 1 | 1996 | 22 | 0.030 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2017 | 75 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2017 | 175 | 0.030 |
Why?
|
Receptors, Interleukin-13 | 1 | 1996 | 2 | 0.030 |
Why?
|
Lymphocyte Subsets | 2 | 2003 | 79 | 0.030 |
Why?
|
RNA Interference | 2 | 2008 | 433 | 0.030 |
Why?
|
Interleukin-13 Receptor alpha1 Subunit | 1 | 1996 | 3 | 0.030 |
Why?
|
Calcimycin | 3 | 1999 | 47 | 0.030 |
Why?
|
Receptors, Interleukin-4 | 1 | 1996 | 15 | 0.030 |
Why?
|
Genetic Markers | 2 | 1995 | 320 | 0.030 |
Why?
|
Osteoclasts | 1 | 1996 | 34 | 0.030 |
Why?
|
Heart Function Tests | 1 | 2016 | 58 | 0.030 |
Why?
|
Regional Blood Flow | 2 | 2016 | 424 | 0.030 |
Why?
|
Sleep Stages | 2 | 1987 | 61 | 0.030 |
Why?
|
Premedication | 3 | 1991 | 36 | 0.030 |
Why?
|
Osteoarthritis | 1 | 1998 | 171 | 0.030 |
Why?
|
Clone Cells | 4 | 1994 | 247 | 0.030 |
Why?
|
Intestinal Diseases | 1 | 2016 | 33 | 0.030 |
Why?
|
Extracorporeal Circulation | 1 | 1996 | 14 | 0.030 |
Why?
|
Plaque, Atherosclerotic | 1 | 2016 | 44 | 0.030 |
Why?
|
Phenylmethylsulfonyl Fluoride | 2 | 1988 | 3 | 0.030 |
Why?
|
Complement C3a | 1 | 1996 | 33 | 0.030 |
Why?
|
Cell Line, Transformed | 2 | 2003 | 133 | 0.030 |
Why?
|
Methylation | 1 | 2016 | 208 | 0.030 |
Why?
|
Rickettsia | 1 | 1995 | 7 | 0.030 |
Why?
|
Energy Intake | 2 | 1996 | 427 | 0.030 |
Why?
|
Feedback | 2 | 1987 | 144 | 0.030 |
Why?
|
Biliary Tract Diseases | 1 | 2016 | 32 | 0.030 |
Why?
|
Cardiomyopathies | 1 | 1999 | 298 | 0.030 |
Why?
|
APACHE | 1 | 2016 | 58 | 0.030 |
Why?
|
Rectum | 3 | 1994 | 153 | 0.030 |
Why?
|
Critical Care | 1 | 2000 | 476 | 0.030 |
Why?
|
Incidence | 2 | 2017 | 2313 | 0.030 |
Why?
|
Pulse Wave Analysis | 1 | 2016 | 207 | 0.030 |
Why?
|
Netherlands | 1 | 2015 | 64 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 1986 | 154 | 0.030 |
Why?
|
Drug Combinations | 2 | 2009 | 287 | 0.030 |
Why?
|
Pyrrolidinones | 1 | 1995 | 25 | 0.030 |
Why?
|
Gene Frequency | 1 | 2017 | 477 | 0.030 |
Why?
|
Molecular Probes | 1 | 1995 | 30 | 0.030 |
Why?
|
Nucleic Acid Conformation | 2 | 1996 | 669 | 0.030 |
Why?
|
Liver Cirrhosis, Biliary | 1 | 1995 | 18 | 0.030 |
Why?
|
Inpatients | 1 | 1999 | 380 | 0.030 |
Why?
|
Genetic Loci | 1 | 2017 | 262 | 0.030 |
Why?
|
Stem Cell Niche | 1 | 2015 | 42 | 0.030 |
Why?
|
Platelet-Derived Growth Factor | 1 | 1995 | 82 | 0.030 |
Why?
|
Steroids | 1 | 2016 | 144 | 0.030 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 2 | 2011 | 127 | 0.030 |
Why?
|
Indonesia | 1 | 2015 | 18 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2016 | 127 | 0.030 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2015 | 10 | 0.030 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2015 | 60 | 0.030 |
Why?
|
Leptospirosis | 1 | 2015 | 6 | 0.030 |
Why?
|
Typhoid Fever | 1 | 2015 | 9 | 0.030 |
Why?
|
Purinergic P2X Receptor Antagonists | 1 | 2015 | 7 | 0.030 |
Why?
|
Amniotic Fluid | 2 | 1992 | 64 | 0.030 |
Why?
|
Astrocytes | 2 | 2015 | 162 | 0.030 |
Why?
|
Plasmids | 1 | 1996 | 343 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fyn | 1 | 2015 | 12 | 0.030 |
Why?
|
Carotid Arteries | 1 | 2016 | 180 | 0.030 |
Why?
|
Locus Coeruleus | 1 | 2015 | 19 | 0.030 |
Why?
|
RNA Splice Sites | 1 | 2015 | 33 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2006 | 1820 | 0.030 |
Why?
|
Blast Crisis | 1 | 1995 | 20 | 0.030 |
Why?
|
Culture Techniques | 3 | 1995 | 78 | 0.030 |
Why?
|
Platelet Function Tests | 1 | 2015 | 24 | 0.030 |
Why?
|
Nootropic Agents | 1 | 2015 | 27 | 0.030 |
Why?
|
Risk Assessment | 2 | 2017 | 2968 | 0.030 |
Why?
|
Multiple Organ Failure | 1 | 2016 | 146 | 0.030 |
Why?
|
Fixatives | 1 | 1994 | 15 | 0.030 |
Why?
|
Mannose | 1 | 1994 | 21 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 1995 | 133 | 0.030 |
Why?
|
Receptor, Ciliary Neurotrophic Factor | 1 | 1994 | 1 | 0.030 |
Why?
|
c-Mer Tyrosine Kinase | 1 | 2015 | 43 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2014 | 1796 | 0.030 |
Why?
|
Dinitrofluorobenzene | 1 | 2014 | 7 | 0.030 |
Why?
|
Mucus | 2 | 1993 | 54 | 0.030 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2014 | 4 | 0.030 |
Why?
|
Pulmonary Surfactant-Associated Protein C | 1 | 2015 | 42 | 0.030 |
Why?
|
Herpesviridae Infections | 2 | 1986 | 138 | 0.030 |
Why?
|
Pyridoxine | 1 | 1995 | 28 | 0.030 |
Why?
|
Haptens | 1 | 2014 | 21 | 0.030 |
Why?
|
Checklist | 1 | 2015 | 83 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2017 | 485 | 0.030 |
Why?
|
Leukocyte Common Antigens | 1 | 2014 | 75 | 0.030 |
Why?
|
Biopsy | 3 | 2011 | 1036 | 0.030 |
Why?
|
Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2014 | 57 | 0.030 |
Why?
|
Feces | 1 | 2017 | 373 | 0.030 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2015 | 68 | 0.030 |
Why?
|
Biotransformation | 2 | 1986 | 48 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2014 | 55 | 0.030 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2015 | 129 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 1 | 2015 | 257 | 0.030 |
Why?
|
CD11c Antigen | 1 | 2014 | 38 | 0.030 |
Why?
|
Lactates | 1 | 2014 | 79 | 0.030 |
Why?
|
Crystallization | 1 | 2015 | 136 | 0.030 |
Why?
|
Angiopoietin-like Proteins | 1 | 2014 | 1 | 0.030 |
Why?
|
Diagnosis, Differential | 3 | 2010 | 1342 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2017 | 740 | 0.030 |
Why?
|
Histocompatibility Testing | 1 | 2014 | 116 | 0.030 |
Why?
|
Calpain | 2 | 2005 | 53 | 0.030 |
Why?
|
Ranitidine | 1 | 1994 | 13 | 0.030 |
Why?
|
Seasons | 1 | 2016 | 442 | 0.030 |
Why?
|
Cytopathogenic Effect, Viral | 2 | 2011 | 15 | 0.030 |
Why?
|
Common Cold | 1 | 1994 | 12 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 1995 | 179 | 0.030 |
Why?
|
PPAR gamma | 1 | 2015 | 182 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2015 | 233 | 0.030 |
Why?
|
Rhinovirus | 1 | 1994 | 40 | 0.030 |
Why?
|
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2014 | 42 | 0.030 |
Why?
|
HLA-B51 Antigen | 1 | 2013 | 2 | 0.030 |
Why?
|
Endostatins | 1 | 2013 | 9 | 0.030 |
Why?
|
Phospholipases A2 | 1 | 1994 | 76 | 0.030 |
Why?
|
Activins | 1 | 2013 | 26 | 0.030 |
Why?
|
Thiazoles | 1 | 1994 | 110 | 0.030 |
Why?
|
Rats, Inbred F344 | 3 | 1989 | 241 | 0.030 |
Why?
|
Cattle | 3 | 2003 | 920 | 0.030 |
Why?
|
GATA3 Transcription Factor | 1 | 2014 | 24 | 0.030 |
Why?
|
Anilides | 1 | 2014 | 67 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2015 | 271 | 0.030 |
Why?
|
Receptor, Anaphylatoxin C5a | 1 | 1994 | 28 | 0.030 |
Why?
|
Amyloid | 2 | 2006 | 80 | 0.030 |
Why?
|
Secretory Rate | 3 | 1990 | 16 | 0.030 |
Why?
|
Organophosphorus Compounds | 1 | 1994 | 72 | 0.030 |
Why?
|
Hepatitis, Viral, Human | 1 | 1993 | 25 | 0.030 |
Why?
|
4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine | 2 | 1984 | 2 | 0.030 |
Why?
|
5,8,11,14-Eicosatetraynoic Acid | 2 | 1984 | 3 | 0.030 |
Why?
|
Biodiversity | 1 | 2017 | 349 | 0.030 |
Why?
|
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 2 | 1990 | 27 | 0.030 |
Why?
|
Leukemic Infiltration | 1 | 2013 | 5 | 0.030 |
Why?
|
Myelin Basic Protein | 2 | 1998 | 45 | 0.030 |
Why?
|
Water | 1 | 1996 | 396 | 0.030 |
Why?
|
Protein Folding | 1 | 2015 | 239 | 0.030 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2016 | 241 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 146 | 0.030 |
Why?
|
Systole | 1 | 2014 | 171 | 0.030 |
Why?
|
Nasal Mucosa | 1 | 1994 | 93 | 0.030 |
Why?
|
Isoquinolines | 2 | 1990 | 36 | 0.030 |
Why?
|
Nitrogen Oxides | 1 | 2013 | 47 | 0.030 |
Why?
|
Tissue Distribution | 2 | 1991 | 286 | 0.030 |
Why?
|
Siblings | 1 | 2014 | 221 | 0.030 |
Why?
|
NIH 3T3 Cells | 2 | 2003 | 137 | 0.030 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2013 | 20 | 0.030 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2013 | 23 | 0.030 |
Why?
|
Receptors, Complement | 1 | 1994 | 111 | 0.030 |
Why?
|
Nanoparticles | 1 | 2017 | 313 | 0.030 |
Why?
|
Telencephalon | 1 | 1993 | 15 | 0.030 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 2 | 1990 | 65 | 0.030 |
Why?
|
Immunity, Active | 1 | 2013 | 9 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 1996 | 723 | 0.030 |
Why?
|
Autophagy-Related Protein-1 Homolog | 1 | 2013 | 6 | 0.030 |
Why?
|
Methods | 2 | 1987 | 58 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 164 | 0.030 |
Why?
|
Pain Measurement | 1 | 2015 | 444 | 0.030 |
Why?
|
Lymphoid Tissue | 1 | 2013 | 62 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2007 | 2765 | 0.030 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2015 | 256 | 0.030 |
Why?
|
Immunoenzyme Techniques | 3 | 1989 | 192 | 0.030 |
Why?
|
Rats, Inbred WKY | 1 | 1993 | 32 | 0.030 |
Why?
|
Cell Membrane Permeability | 1 | 2013 | 83 | 0.030 |
Why?
|
Anti-Retroviral Agents | 1 | 2015 | 207 | 0.030 |
Why?
|
Emphysema | 1 | 2014 | 107 | 0.030 |
Why?
|
Hyphae | 1 | 2012 | 7 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2012 | 1167 | 0.030 |
Why?
|
Familial Primary Pulmonary Hypertension | 1 | 2013 | 190 | 0.030 |
Why?
|
Thyroidectomy | 1 | 2013 | 53 | 0.030 |
Why?
|
Amnion | 2 | 1992 | 24 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2015 | 226 | 0.030 |
Why?
|
Muscle Strength | 1 | 2015 | 271 | 0.030 |
Why?
|
Polysaccharides, Bacterial | 1 | 1993 | 66 | 0.030 |
Why?
|
Caenorhabditis elegans | 1 | 1996 | 268 | 0.030 |
Why?
|
Enteral Nutrition | 1 | 1994 | 160 | 0.030 |
Why?
|
Lipid A | 2 | 1990 | 28 | 0.030 |
Why?
|
Retroviridae Proteins | 2 | 1989 | 11 | 0.030 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2016 | 287 | 0.030 |
Why?
|
Cartilage, Articular | 2 | 2003 | 289 | 0.030 |
Why?
|
Hemorrhage | 1 | 1997 | 620 | 0.030 |
Why?
|
Capillary Permeability | 1 | 2013 | 139 | 0.030 |
Why?
|
Hospitals, General | 1 | 1992 | 19 | 0.030 |
Why?
|
Spores, Fungal | 1 | 2012 | 20 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2014 | 174 | 0.030 |
Why?
|
DNA Methylation | 1 | 2017 | 496 | 0.030 |
Why?
|
Caspases, Initiator | 1 | 2012 | 18 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 329 | 0.030 |
Why?
|
Body Surface Area | 1 | 1992 | 27 | 0.030 |
Why?
|
Carbohydrate Conformation | 1 | 1992 | 15 | 0.030 |
Why?
|
Ketone Bodies | 1 | 1992 | 15 | 0.030 |
Why?
|
Burn Units | 1 | 1992 | 26 | 0.030 |
Why?
|
Chemokine CXCL10 | 1 | 2012 | 34 | 0.030 |
Why?
|
Calcium Signaling | 2 | 2006 | 217 | 0.030 |
Why?
|
Inhalation Exposure | 1 | 2013 | 97 | 0.030 |
Why?
|
Ureaplasma Infections | 1 | 1992 | 3 | 0.030 |
Why?
|
Haptoglobins | 2 | 1984 | 47 | 0.030 |
Why?
|
Drug Therapy | 1 | 1993 | 76 | 0.030 |
Why?
|
Ureaplasma urealyticum | 1 | 1992 | 3 | 0.030 |
Why?
|
Cell-Free System | 3 | 2001 | 47 | 0.030 |
Why?
|
Mycoplasma Infections | 1 | 1992 | 13 | 0.030 |
Why?
|
Fusobacterium Infections | 1 | 1992 | 6 | 0.030 |
Why?
|
Syndrome | 1 | 1993 | 333 | 0.020 |
Why?
|
Pandemics | 1 | 2020 | 1320 | 0.020 |
Why?
|
Tobacco Products | 1 | 2013 | 98 | 0.020 |
Why?
|
Bleomycin | 1 | 1973 | 228 | 0.020 |
Why?
|
Pregnancy Trimester, Second | 1 | 1992 | 66 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2016 | 641 | 0.020 |
Why?
|
Paxillin | 1 | 2011 | 10 | 0.020 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 1992 | 34 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2017 | 651 | 0.020 |
Why?
|
Pregnancy Trimester, Third | 1 | 1992 | 79 | 0.020 |
Why?
|
Retinal Vasculitis | 1 | 2011 | 7 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 2 | 1998 | 124 | 0.020 |
Why?
|
Plant Lectins | 1 | 1991 | 8 | 0.020 |
Why?
|
Transcriptome | 1 | 2017 | 726 | 0.020 |
Why?
|
Acetyltransferases | 1 | 1991 | 20 | 0.020 |
Why?
|
Central Nervous System | 3 | 1997 | 235 | 0.020 |
Why?
|
Soybean Proteins | 1 | 1991 | 10 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 1075 | 0.020 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2011 | 39 | 0.020 |
Why?
|
Bacillus subtilis | 1 | 1992 | 58 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2015 | 608 | 0.020 |
Why?
|
Cholera Toxin | 1 | 1991 | 27 | 0.020 |
Why?
|
Dactinomycin | 1 | 1991 | 25 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2011 | 197 | 0.020 |
Why?
|
Diphenhydramine | 1 | 1991 | 30 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2011 | 98 | 0.020 |
Why?
|
Integrins | 1 | 2011 | 79 | 0.020 |
Why?
|
Gastrointestinal Tract | 1 | 2013 | 169 | 0.020 |
Why?
|
Vesicular Stomatitis | 1 | 2011 | 3 | 0.020 |
Why?
|
Diet, Atherogenic | 1 | 2011 | 6 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2015 | 401 | 0.020 |
Why?
|
Exotoxins | 2 | 2002 | 14 | 0.020 |
Why?
|
P-Selectin | 1 | 2011 | 25 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 2 | 2004 | 383 | 0.020 |
Why?
|
Glioblastoma | 1 | 2013 | 253 | 0.020 |
Why?
|
Perfusion | 3 | 2004 | 148 | 0.020 |
Why?
|
Piperazines | 2 | 1990 | 309 | 0.020 |
Why?
|
Herpes Genitalis | 1 | 2011 | 16 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2013 | 339 | 0.020 |
Why?
|
Nerve Regeneration | 1 | 1991 | 50 | 0.020 |
Why?
|
Foam Cells | 1 | 2011 | 13 | 0.020 |
Why?
|
Nucleotides, Cyclic | 1 | 1991 | 15 | 0.020 |
Why?
|
Sciatic Nerve | 1 | 1991 | 56 | 0.020 |
Why?
|
Vero Cells | 1 | 2011 | 63 | 0.020 |
Why?
|
Ambroxol | 1 | 1990 | 1 | 0.020 |
Why?
|
Streptozocin | 1 | 2010 | 16 | 0.020 |
Why?
|
Cell-Derived Microparticles | 1 | 2011 | 57 | 0.020 |
Why?
|
Basophils | 2 | 1988 | 64 | 0.020 |
Why?
|
Bucladesine | 1 | 1990 | 24 | 0.020 |
Why?
|
Staurosporine | 1 | 1990 | 21 | 0.020 |
Why?
|
Antigen-Presenting Cells | 3 | 1986 | 150 | 0.020 |
Why?
|
Alkaloids | 1 | 1990 | 22 | 0.020 |
Why?
|
Lymphocyte Cooperation | 3 | 1985 | 49 | 0.020 |
Why?
|
Colforsin | 1 | 1990 | 48 | 0.020 |
Why?
|
Nitrites | 1 | 2010 | 75 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 2011 | 80 | 0.020 |
Why?
|
Health Status | 1 | 2015 | 722 | 0.020 |
Why?
|
Cytoplasmic Granules | 2 | 1989 | 82 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 1991 | 181 | 0.020 |
Why?
|
HIV-2 | 1 | 1990 | 15 | 0.020 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2011 | 170 | 0.020 |
Why?
|
Pituitary Gland, Anterior | 1 | 1990 | 39 | 0.020 |
Why?
|
Lymphoma, B-Cell | 1 | 1991 | 86 | 0.020 |
Why?
|
Adenylyl Cyclases | 1 | 1990 | 83 | 0.020 |
Why?
|
Frontal Lobe | 2 | 1990 | 141 | 0.020 |
Why?
|
Calmodulin | 1 | 1990 | 71 | 0.020 |
Why?
|
Odds Ratio | 1 | 2013 | 953 | 0.020 |
Why?
|
Trypsin | 2 | 1984 | 66 | 0.020 |
Why?
|
Receptors, GABA-A | 1 | 1991 | 82 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2011 | 222 | 0.020 |
Why?
|
Poly A | 2 | 1994 | 46 | 0.020 |
Why?
|
Serum Albumin | 2 | 1988 | 137 | 0.020 |
Why?
|
Imidazolines | 1 | 2010 | 3 | 0.020 |
Why?
|
Hypercholesterolemia | 1 | 2011 | 90 | 0.020 |
Why?
|
Mental Health | 1 | 2015 | 562 | 0.020 |
Why?
|
Pulmonary Fibrosis | 1 | 2013 | 323 | 0.020 |
Why?
|
HIV Envelope Protein gp120 | 1 | 1990 | 56 | 0.020 |
Why?
|
Fluorescence Recovery After Photobleaching | 1 | 2010 | 18 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 1990 | 114 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2009 | 49 | 0.020 |
Why?
|
Software | 2 | 2011 | 530 | 0.020 |
Why?
|
Research Design | 1 | 2015 | 928 | 0.020 |
Why?
|
Membrane Microdomains | 1 | 2009 | 32 | 0.020 |
Why?
|
Visual Acuity | 1 | 2011 | 274 | 0.020 |
Why?
|
Edema | 1 | 1990 | 119 | 0.020 |
Why?
|
Clusterin | 1 | 2009 | 10 | 0.020 |
Why?
|
Toll-Like Receptor 6 | 1 | 2009 | 2 | 0.020 |
Why?
|
Toll-Like Receptor 1 | 1 | 2009 | 11 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2010 | 90 | 0.020 |
Why?
|
Histocytochemistry | 2 | 1987 | 78 | 0.020 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2009 | 34 | 0.020 |
Why?
|
Feeding Behavior | 1 | 1995 | 574 | 0.020 |
Why?
|
Mice, SCID | 1 | 2010 | 314 | 0.020 |
Why?
|
Adenoviridae | 1 | 2010 | 184 | 0.020 |
Why?
|
Hepacivirus | 1 | 2011 | 229 | 0.020 |
Why?
|
Neisseria meningitidis | 1 | 1989 | 18 | 0.020 |
Why?
|
Gluconeogenesis | 2 | 2006 | 62 | 0.020 |
Why?
|
Lymphotoxin-alpha | 3 | 1996 | 7 | 0.020 |
Why?
|
Probability | 1 | 2010 | 289 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 2 | 1994 | 225 | 0.020 |
Why?
|
Arteries | 1 | 1991 | 247 | 0.020 |
Why?
|
Genes, Immunoglobulin | 1 | 1989 | 26 | 0.020 |
Why?
|
3T3 Cells | 2 | 2004 | 140 | 0.020 |
Why?
|
Malaria | 1 | 1989 | 48 | 0.020 |
Why?
|
Aprotinin | 1 | 1988 | 9 | 0.020 |
Why?
|
Tetanus Toxoid | 2 | 1986 | 37 | 0.020 |
Why?
|
Central Venous Pressure | 1 | 1988 | 12 | 0.020 |
Why?
|
Mast Cells | 1 | 2009 | 116 | 0.020 |
Why?
|
Leucine | 4 | 1996 | 102 | 0.020 |
Why?
|
Somatostatin | 1 | 1989 | 52 | 0.020 |
Why?
|
Ear | 1 | 1988 | 32 | 0.020 |
Why?
|
Thyroglobulin | 1 | 1988 | 17 | 0.020 |
Why?
|
Brain Stem | 1 | 1989 | 101 | 0.020 |
Why?
|
Cell Transformation, Viral | 2 | 1986 | 24 | 0.020 |
Why?
|
Blood Urea Nitrogen | 1 | 2008 | 51 | 0.020 |
Why?
|
Subcellular Fractions | 1 | 1988 | 78 | 0.020 |
Why?
|
Lithostathine | 1 | 2008 | 1 | 0.020 |
Why?
|
Pancreatitis-Associated Proteins | 1 | 2008 | 5 | 0.020 |
Why?
|
Oleic Acids | 1 | 1988 | 10 | 0.020 |
Why?
|
Natriuresis | 1 | 1988 | 8 | 0.020 |
Why?
|
Stearic Acids | 1 | 1988 | 12 | 0.020 |
Why?
|
Leukemia, Erythroblastic, Acute | 2 | 1985 | 8 | 0.020 |
Why?
|
Amylases | 1 | 2008 | 13 | 0.020 |
Why?
|
Phosphorylcholine | 1 | 1988 | 17 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2010 | 222 | 0.020 |
Why?
|
Cardiac Output | 1 | 1988 | 143 | 0.020 |
Why?
|
Tumor Necrosis Factor Decoy Receptors | 2 | 1999 | 7 | 0.020 |
Why?
|
Respiratory Burst | 2 | 2002 | 28 | 0.020 |
Why?
|
Skin Tests | 3 | 1994 | 116 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 811 | 0.020 |
Why?
|
Cytokine Receptor gp130 | 2 | 1999 | 10 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2010 | 371 | 0.020 |
Why?
|
Patient Admission | 1 | 2010 | 176 | 0.020 |
Why?
|
Theophylline | 1 | 1988 | 60 | 0.020 |
Why?
|
Molecular Chaperones | 1 | 2009 | 157 | 0.020 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2009 | 170 | 0.020 |
Why?
|
Lipase | 1 | 2008 | 55 | 0.020 |
Why?
|
Thyroid Gland | 1 | 1988 | 82 | 0.020 |
Why?
|
Epitope Mapping | 1 | 2008 | 51 | 0.020 |
Why?
|
Culture Media, Serum-Free | 1 | 2007 | 42 | 0.020 |
Why?
|
Myocardial Depressant Factor | 1 | 2007 | 2 | 0.020 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2007 | 41 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 1990 | 256 | 0.020 |
Why?
|
Molecular Structure | 1 | 1989 | 434 | 0.020 |
Why?
|
Microchemistry | 1 | 1987 | 15 | 0.020 |
Why?
|
Bile | 1 | 1987 | 26 | 0.020 |
Why?
|
Adrenal Cortex | 1 | 1987 | 32 | 0.020 |
Why?
|
Cysteine | 1 | 2008 | 171 | 0.020 |
Why?
|
Protein Deficiency | 1 | 1987 | 3 | 0.020 |
Why?
|
Reference Standards | 1 | 1988 | 159 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2010 | 292 | 0.020 |
Why?
|
Denmark | 2 | 2000 | 39 | 0.020 |
Why?
|
Echocardiography | 1 | 2010 | 553 | 0.020 |
Why?
|
Cytotoxins | 1 | 1987 | 17 | 0.020 |
Why?
|
Vacuoles | 1 | 1987 | 33 | 0.020 |
Why?
|
Hyperbaric Oxygenation | 1 | 1987 | 36 | 0.020 |
Why?
|
Proinsulin | 1 | 1987 | 48 | 0.020 |
Why?
|
Parenteral Nutrition, Total | 1 | 1987 | 27 | 0.020 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2007 | 98 | 0.020 |
Why?
|
Receptors, Angiotensin | 1 | 1987 | 9 | 0.020 |
Why?
|
United States | 2 | 2011 | 12186 | 0.020 |
Why?
|
Deamino Arginine Vasopressin | 1 | 1987 | 10 | 0.020 |
Why?
|
7-Alkoxycoumarin O-Dealkylase | 1 | 1986 | 1 | 0.020 |
Why?
|
Angiotensinogen | 1 | 2006 | 4 | 0.020 |
Why?
|
Kidney Cortex | 1 | 2006 | 23 | 0.020 |
Why?
|
Leukopenia | 1 | 1987 | 27 | 0.020 |
Why?
|
Oxygenases | 1 | 1986 | 9 | 0.020 |
Why?
|
Drug Compounding | 1 | 2007 | 89 | 0.020 |
Why?
|
Arginine Vasopressin | 1 | 1987 | 46 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2007 | 132 | 0.020 |
Why?
|
Chemical Fractionation | 1 | 1986 | 28 | 0.020 |
Why?
|
Collagen Type IV | 1 | 2006 | 22 | 0.020 |
Why?
|
Phospholipids | 1 | 1988 | 197 | 0.020 |
Why?
|
Cytochalasin B | 2 | 1984 | 17 | 0.020 |
Why?
|
Staining and Labeling | 1 | 1987 | 134 | 0.020 |
Why?
|
Hepatitis, Alcoholic | 1 | 1986 | 13 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 2007 | 159 | 0.020 |
Why?
|
Newcastle disease virus | 1 | 1986 | 17 | 0.020 |
Why?
|
Genome, Human | 1 | 2008 | 347 | 0.020 |
Why?
|
Ureter | 1 | 2006 | 31 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2007 | 292 | 0.020 |
Why?
|
Phospholipases | 1 | 2006 | 12 | 0.020 |
Why?
|
Cell Adhesion Molecules | 2 | 2003 | 168 | 0.020 |
Why?
|
Carcinogens | 1 | 2007 | 103 | 0.020 |
Why?
|
Cell Fractionation | 1 | 2006 | 51 | 0.020 |
Why?
|
HIV | 1 | 1987 | 208 | 0.020 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 1986 | 28 | 0.020 |
Why?
|
Peptide Hydrolases | 2 | 1984 | 104 | 0.020 |
Why?
|
Fibrinogen | 2 | 1984 | 154 | 0.020 |
Why?
|
Vasculitis | 1 | 1986 | 66 | 0.020 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 1986 | 108 | 0.020 |
Why?
|
Receptors, Adiponectin | 1 | 2006 | 15 | 0.020 |
Why?
|
Collagen Type I | 1 | 2006 | 108 | 0.020 |
Why?
|
K562 Cells | 1 | 2006 | 73 | 0.020 |
Why?
|
Chromatography | 1 | 1986 | 23 | 0.020 |
Why?
|
Chemical Precipitation | 2 | 1977 | 37 | 0.020 |
Why?
|
Consensus Sequence | 2 | 1996 | 70 | 0.020 |
Why?
|
Cyclic GMP | 2 | 1999 | 80 | 0.020 |
Why?
|
Fibroblast Growth Factor 7 | 1 | 2005 | 16 | 0.020 |
Why?
|
Histamine Release | 1 | 1985 | 20 | 0.020 |
Why?
|
Receptors, Opioid | 1 | 1985 | 19 | 0.020 |
Why?
|
Organ Culture Techniques | 3 | 1991 | 140 | 0.020 |
Why?
|
Leishmania | 1 | 1985 | 2 | 0.020 |
Why?
|
Craniocerebral Trauma | 1 | 1987 | 134 | 0.020 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2005 | 23 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 2286 | 0.020 |
Why?
|
Nod1 Signaling Adaptor Protein | 1 | 2005 | 12 | 0.020 |
Why?
|
Potassium | 1 | 2006 | 128 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 3 | 1992 | 151 | 0.020 |
Why?
|
Antigens, Protozoan | 1 | 1985 | 19 | 0.020 |
Why?
|
Human papillomavirus 16 | 1 | 2005 | 25 | 0.020 |
Why?
|
CD8 Antigens | 1 | 2005 | 69 | 0.020 |
Why?
|
Major Histocompatibility Complex | 1 | 1986 | 217 | 0.020 |
Why?
|
Physical Endurance | 1 | 1986 | 232 | 0.020 |
Why?
|
Epitopes | 2 | 1985 | 435 | 0.020 |
Why?
|
Lymphopenia | 1 | 2005 | 49 | 0.020 |
Why?
|
Puromycin | 1 | 1985 | 11 | 0.020 |
Why?
|
Follicular Phase | 1 | 1985 | 36 | 0.020 |
Why?
|
Leukemia P388 | 1 | 1985 | 7 | 0.020 |
Why?
|
Phorbols | 1 | 1985 | 10 | 0.020 |
Why?
|
Herpesvirus 4, Human | 4 | 1986 | 125 | 0.020 |
Why?
|
Nutritional Status | 2 | 1998 | 287 | 0.020 |
Why?
|
Ovulation | 1 | 1985 | 39 | 0.020 |
Why?
|
Lipodystrophy | 1 | 2005 | 16 | 0.020 |
Why?
|
DNA Restriction Enzymes | 1 | 1984 | 54 | 0.020 |
Why?
|
Antitoxins | 1 | 1984 | 1 | 0.020 |
Why?
|
Reticulocytes | 1 | 1984 | 16 | 0.020 |
Why?
|
DNA Probes | 1 | 2004 | 59 | 0.020 |
Why?
|
Leukocytosis | 1 | 2005 | 34 | 0.020 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2005 | 54 | 0.020 |
Why?
|
Leukemia, Experimental | 1 | 1985 | 27 | 0.020 |
Why?
|
Zea mays | 1 | 2005 | 39 | 0.010 |
Why?
|
Caspase 9 | 1 | 2004 | 48 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 1990 | 785 | 0.010 |
Why?
|
Macrophage-Activating Factors | 1 | 1984 | 4 | 0.010 |
Why?
|
Bone and Bones | 1 | 1987 | 279 | 0.010 |
Why?
|
Leukocyte Migration-Inhibitory Factors | 1 | 1984 | 1 | 0.010 |
Why?
|
Edetic Acid | 2 | 1995 | 47 | 0.010 |
Why?
|
Absorption | 1 | 1984 | 52 | 0.010 |
Why?
|
Thrombosis | 1 | 1987 | 298 | 0.010 |
Why?
|
Arginase | 1 | 1984 | 27 | 0.010 |
Why?
|
Ovum | 1 | 1984 | 28 | 0.010 |
Why?
|
Host-Parasite Interactions | 1 | 1985 | 94 | 0.010 |
Why?
|
Human Growth Hormone | 1 | 1984 | 38 | 0.010 |
Why?
|
Oxygen | 1 | 1989 | 854 | 0.010 |
Why?
|
Freeze Drying | 1 | 1984 | 75 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 213 | 0.010 |
Why?
|
Oxidants, Photochemical | 1 | 2004 | 6 | 0.010 |
Why?
|
Bronchoconstrictor Agents | 1 | 2004 | 14 | 0.010 |
Why?
|
Sclerosis | 1 | 1984 | 11 | 0.010 |
Why?
|
Electroencephalography | 4 | 1987 | 362 | 0.010 |
Why?
|
Methacholine Chloride | 1 | 2004 | 47 | 0.010 |
Why?
|
Chemistry, Physical | 1 | 1984 | 37 | 0.010 |
Why?
|
Surveys and Questionnaires | 1 | 2015 | 4624 | 0.010 |
Why?
|
Peritoneum | 1 | 1984 | 36 | 0.010 |
Why?
|
Microtubules | 1 | 2006 | 237 | 0.010 |
Why?
|
Hypersensitivity, Delayed | 2 | 1994 | 27 | 0.010 |
Why?
|
Arachidonic Acid | 1 | 1984 | 116 | 0.010 |
Why?
|
Glioma | 1 | 1987 | 294 | 0.010 |
Why?
|
Cations | 1 | 1984 | 78 | 0.010 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2003 | 58 | 0.010 |
Why?
|
Pokeweed Mitogens | 1 | 1983 | 6 | 0.010 |
Why?
|
Binding Sites, Antibody | 1 | 1983 | 36 | 0.010 |
Why?
|
Anemia | 1 | 1984 | 143 | 0.010 |
Why?
|
Lupus Nephritis | 1 | 2003 | 52 | 0.010 |
Why?
|
Electric Impedance | 1 | 2003 | 100 | 0.010 |
Why?
|
Epidermis | 1 | 1984 | 149 | 0.010 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2003 | 28 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2007 | 927 | 0.010 |
Why?
|
Nitrogen | 3 | 1989 | 143 | 0.010 |
Why?
|
Hypertension, Pulmonary | 1 | 2013 | 1729 | 0.010 |
Why?
|
Protein Subunits | 1 | 2003 | 201 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 3 | 1988 | 43 | 0.010 |
Why?
|
Receptors, Formyl Peptide | 1 | 2002 | 9 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2006 | 633 | 0.010 |
Why?
|
Receptors, Peptide | 1 | 2002 | 18 | 0.010 |
Why?
|
Respiration | 3 | 1988 | 180 | 0.010 |
Why?
|
Integrin beta1 | 1 | 2002 | 17 | 0.010 |
Why?
|
Cortisone | 1 | 1982 | 8 | 0.010 |
Why?
|
Virus Physiological Phenomena | 1 | 1982 | 6 | 0.010 |
Why?
|
Cell Size | 1 | 2002 | 80 | 0.010 |
Why?
|
Sonication | 1 | 2002 | 10 | 0.010 |
Why?
|
Carboxypeptidase B | 1 | 1982 | 2 | 0.010 |
Why?
|
Carboxypeptidases | 1 | 1982 | 12 | 0.010 |
Why?
|
Chelating Agents | 1 | 2002 | 65 | 0.010 |
Why?
|
Halogens | 1 | 1982 | 13 | 0.010 |
Why?
|
Hyaluronan Receptors | 1 | 2002 | 90 | 0.010 |
Why?
|
Drug Evaluation | 2 | 1988 | 77 | 0.010 |
Why?
|
Indicators and Reagents | 1 | 1982 | 99 | 0.010 |
Why?
|
Vitamin E | 2 | 1993 | 110 | 0.010 |
Why?
|
Type C Phospholipases | 1 | 2002 | 65 | 0.010 |
Why?
|
Isoxazoles | 1 | 1982 | 51 | 0.010 |
Why?
|
Receptors, Interleukin-6 | 1 | 2001 | 34 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2008 | 2387 | 0.010 |
Why?
|
Temperature | 2 | 1996 | 565 | 0.010 |
Why?
|
Ileum | 1 | 2002 | 90 | 0.010 |
Why?
|
Mortality | 1 | 2003 | 287 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 2005 | 604 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2003 | 511 | 0.010 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2001 | 9 | 0.010 |
Why?
|
Bacterial Physiological Phenomena | 1 | 1982 | 57 | 0.010 |
Why?
|
Tuberculin | 2 | 1994 | 6 | 0.010 |
Why?
|
Chorionic Gonadotropin | 1 | 1981 | 78 | 0.010 |
Why?
|
Guinea Pigs | 3 | 1987 | 136 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2003 | 275 | 0.010 |
Why?
|
Smoking | 1 | 2008 | 1383 | 0.010 |
Why?
|
Tyrosine | 1 | 1982 | 214 | 0.010 |
Why?
|
Neurons | 3 | 1995 | 1280 | 0.010 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2004 | 333 | 0.010 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 1995 | 98 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 1984 | 615 | 0.010 |
Why?
|
Albumins | 1 | 1981 | 89 | 0.010 |
Why?
|
Rats, Inbred WF | 1 | 2000 | 5 | 0.010 |
Why?
|
Hyaluronic Acid | 1 | 2002 | 190 | 0.010 |
Why?
|
Centrifugation, Density Gradient | 2 | 1990 | 40 | 0.010 |
Why?
|
Zinc | 3 | 1987 | 260 | 0.010 |
Why?
|
Cesarean Section | 1 | 1981 | 169 | 0.010 |
Why?
|
Ionophores | 1 | 1999 | 22 | 0.010 |
Why?
|
Tuftsin | 1 | 1979 | 4 | 0.010 |
Why?
|
gamma-Globulins | 1 | 1979 | 18 | 0.010 |
Why?
|
HLA-DR4 Antigen | 1 | 2000 | 76 | 0.010 |
Why?
|
Tritium | 2 | 1990 | 66 | 0.010 |
Why?
|
HLA-DR3 Antigen | 1 | 2000 | 79 | 0.010 |
Why?
|
Nitroprusside | 1 | 1999 | 64 | 0.010 |
Why?
|
Immunologic Techniques | 2 | 1990 | 39 | 0.010 |
Why?
|
Ceramidases | 1 | 1999 | 4 | 0.010 |
Why?
|
Amidohydrolases | 1 | 1999 | 28 | 0.010 |
Why?
|
Coronary Care Units | 1 | 1999 | 13 | 0.010 |
Why?
|
Glycerol | 2 | 1991 | 84 | 0.010 |
Why?
|
Sphingosine | 1 | 1999 | 33 | 0.010 |
Why?
|
Poxviridae | 1 | 1999 | 2 | 0.010 |
Why?
|
Myocardial Reperfusion | 1 | 1999 | 50 | 0.010 |
Why?
|
Heterozygote | 1 | 2000 | 251 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 3053 | 0.010 |
Why?
|
Colorado | 1 | 2008 | 4100 | 0.010 |
Why?
|
Orosomucoid | 2 | 1993 | 5 | 0.010 |
Why?
|
Acetylcholine | 1 | 1999 | 166 | 0.010 |
Why?
|
Receptors, Leptin | 1 | 1999 | 24 | 0.010 |
Why?
|
Troponin T | 1 | 1999 | 49 | 0.010 |
Why?
|
Chromatography, Gas | 1 | 1998 | 27 | 0.010 |
Why?
|
Body Water | 1 | 1998 | 19 | 0.010 |
Why?
|
Diet | 2 | 1997 | 1080 | 0.010 |
Why?
|
Glucuronidase | 2 | 1989 | 42 | 0.010 |
Why?
|
Chondrocytes | 1 | 2000 | 199 | 0.010 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 1998 | 23 | 0.010 |
Why?
|
Phosphoprotein Phosphatases | 1 | 1998 | 64 | 0.010 |
Why?
|
Introns | 1 | 1999 | 227 | 0.010 |
Why?
|
Drug Interactions | 2 | 1989 | 338 | 0.010 |
Why?
|
Portacaval Shunt, Surgical | 2 | 1989 | 2 | 0.010 |
Why?
|
Epithelium | 2 | 1990 | 295 | 0.010 |
Why?
|
Thymidine | 2 | 1990 | 58 | 0.010 |
Why?
|
Vasodilator Agents | 1 | 1999 | 302 | 0.010 |
Why?
|
Dogs | 1 | 1998 | 334 | 0.010 |
Why?
|
Meningitis, Meningococcal | 1 | 1997 | 5 | 0.010 |
Why?
|
Bacteriological Techniques | 1 | 1998 | 65 | 0.010 |
Why?
|
Chromatography, Ion Exchange | 1 | 1977 | 48 | 0.010 |
Why?
|
Luminescent Measurements | 1 | 1998 | 74 | 0.010 |
Why?
|
Phentolamine | 1 | 1997 | 14 | 0.010 |
Why?
|
Cross Reactions | 1 | 1977 | 117 | 0.010 |
Why?
|
Hand | 1 | 1998 | 134 | 0.010 |
Why?
|
Receptors, Adrenergic | 1 | 1997 | 35 | 0.010 |
Why?
|
Circadian Rhythm | 2 | 1997 | 356 | 0.010 |
Why?
|
Cardiopulmonary Bypass | 1 | 1998 | 178 | 0.010 |
Why?
|
Blood Donors | 1 | 1998 | 89 | 0.010 |
Why?
|
Viral Proteins | 1 | 1999 | 281 | 0.010 |
Why?
|
Forecasting | 1 | 1998 | 330 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2003 | 795 | 0.010 |
Why?
|
Copper | 2 | 1987 | 100 | 0.010 |
Why?
|
Skin Window Technique | 1 | 1976 | 2 | 0.010 |
Why?
|
Granuloma | 2 | 1989 | 83 | 0.010 |
Why?
|
Democratic Republic of the Congo | 1 | 1996 | 22 | 0.010 |
Why?
|
Leukemia Inhibitory Factor | 1 | 1996 | 6 | 0.010 |
Why?
|
Oncostatin M | 1 | 1996 | 6 | 0.010 |
Why?
|
Antibody Specificity | 2 | 1988 | 176 | 0.010 |
Why?
|
Autoantibodies | 1 | 2003 | 1349 | 0.010 |
Why?
|
Epoprostenol | 2 | 1987 | 133 | 0.010 |
Why?
|
Etiocholanolone | 2 | 1986 | 7 | 0.010 |
Why?
|
Radiography | 1 | 1998 | 812 | 0.010 |
Why?
|
Rolipram | 1 | 1995 | 3 | 0.010 |
Why?
|
Pentoxifylline | 1 | 1995 | 21 | 0.010 |
Why?
|
ATPases Associated with Diverse Cellular Activities | 1 | 1995 | 4 | 0.010 |
Why?
|
Captopril | 1 | 1995 | 10 | 0.010 |
Why?
|
Phenol | 1 | 1995 | 18 | 0.010 |
Why?
|
Drug Eruptions | 1 | 1995 | 26 | 0.010 |
Why?
|
Macaca | 1 | 1975 | 50 | 0.010 |
Why?
|
Iron | 2 | 1987 | 233 | 0.010 |
Why?
|
Bilirubin | 1 | 1995 | 88 | 0.010 |
Why?
|
Hematopoiesis, Extramedullary | 1 | 1995 | 5 | 0.010 |
Why?
|
Macaca mulatta | 1 | 1975 | 131 | 0.010 |
Why?
|
Hypertension | 1 | 2003 | 1056 | 0.010 |
Why?
|
Interphase | 2 | 1985 | 32 | 0.010 |
Why?
|
Pituitary-Adrenal System | 1 | 1996 | 130 | 0.010 |
Why?
|
Pyridoxal Phosphate | 1 | 1995 | 20 | 0.010 |
Why?
|
Smoke Inhalation Injury | 1 | 1995 | 19 | 0.010 |
Why?
|
Chick Embryo | 1 | 1995 | 122 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1998 | 395 | 0.010 |
Why?
|
Genetic Linkage | 1 | 1995 | 294 | 0.010 |
Why?
|
Tablets | 1 | 1974 | 36 | 0.010 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 1996 | 164 | 0.010 |
Why?
|
Food, Formulated | 1 | 1994 | 14 | 0.010 |
Why?
|
Dialysis | 1 | 1974 | 17 | 0.010 |
Why?
|
Neuraminidase | 1 | 1974 | 22 | 0.010 |
Why?
|
Menstruation | 1 | 1994 | 35 | 0.010 |
Why?
|
Fat Emulsions, Intravenous | 1 | 1994 | 27 | 0.010 |
Why?
|
Antigens, Dermatophagoides | 1 | 1994 | 10 | 0.010 |
Why?
|
Mites | 1 | 1994 | 3 | 0.010 |
Why?
|
Streptokinase | 1 | 1994 | 10 | 0.010 |
Why?
|
Vitamin B 12 | 1 | 1995 | 115 | 0.010 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 1994 | 27 | 0.010 |
Why?
|
Shwartzman Phenomenon | 1 | 1973 | 1 | 0.010 |
Why?
|
DNA, Satellite | 1 | 1994 | 16 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 1996 | 445 | 0.010 |
Why?
|
Octoxynol | 1 | 1993 | 11 | 0.010 |
Why?
|
Weight Gain | 1 | 1997 | 453 | 0.010 |
Why?
|
Folic Acid | 1 | 1995 | 161 | 0.010 |
Why?
|
Hemoglobins | 1 | 1996 | 315 | 0.010 |
Why?
|
Phagocyte Bactericidal Dysfunction | 1 | 1973 | 12 | 0.010 |
Why?
|
Hypersensitivity, Immediate | 1 | 1994 | 46 | 0.010 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 1994 | 61 | 0.010 |
Why?
|
Lung Abscess | 1 | 1973 | 6 | 0.010 |
Why?
|
Detergents | 1 | 1993 | 41 | 0.010 |
Why?
|
Nocardia Infections | 1 | 1973 | 7 | 0.010 |
Why?
|
DNA Replication | 2 | 1986 | 202 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1994 | 292 | 0.010 |
Why?
|
Genomic Library | 1 | 1993 | 15 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1993 | 68 | 0.010 |
Why?
|
Base Composition | 1 | 1993 | 75 | 0.010 |
Why?
|
Chorion | 1 | 1992 | 5 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1993 | 138 | 0.010 |
Why?
|
Injury Severity Score | 1 | 1995 | 499 | 0.010 |
Why?
|
HLA Antigens | 1 | 1994 | 225 | 0.010 |
Why?
|
Age of Onset | 1 | 1994 | 446 | 0.010 |
Why?
|
Prostaglandin Antagonists | 1 | 1992 | 2 | 0.010 |
Why?
|
RNA, Viral | 1 | 1995 | 565 | 0.010 |
Why?
|
Papio | 1 | 1992 | 96 | 0.010 |
Why?
|
Tibia | 1 | 1973 | 166 | 0.010 |
Why?
|
Osteomyelitis | 1 | 1973 | 105 | 0.010 |
Why?
|
Polyvinyls | 1 | 1991 | 17 | 0.010 |
Why?
|
Chylomicrons | 1 | 1991 | 6 | 0.010 |
Why?
|
Muscimol | 1 | 1991 | 19 | 0.010 |
Why?
|
Synaptosomes | 1 | 1991 | 12 | 0.010 |
Why?
|
Listeria monocytogenes | 1 | 1992 | 111 | 0.010 |
Why?
|
Drug Implants | 1 | 1991 | 70 | 0.010 |
Why?
|
Prostaglandin D2 | 1 | 1990 | 21 | 0.010 |
Why?
|
Pollen | 1 | 1990 | 24 | 0.010 |
Why?
|
Intestine, Small | 1 | 1991 | 122 | 0.010 |
Why?
|
RNA Probes | 1 | 1990 | 13 | 0.010 |
Why?
|
Acetyl-CoA Carboxylase | 1 | 1990 | 33 | 0.010 |
Why?
|
Acyl Coenzyme A | 1 | 1990 | 30 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 1994 | 1430 | 0.010 |
Why?
|
Receptors, IgG | 1 | 1990 | 67 | 0.010 |
Why?
|
Citrates | 1 | 1990 | 43 | 0.010 |
Why?
|
Hospitalization | 1 | 1999 | 1752 | 0.010 |
Why?
|
Citric Acid | 1 | 1990 | 30 | 0.010 |
Why?
|
Chlorides | 1 | 1991 | 127 | 0.010 |
Why?
|
Receptors, Fc | 1 | 1990 | 45 | 0.010 |
Why?
|
Carbohydrate Sequence | 1 | 1990 | 23 | 0.010 |
Why?
|
Blood Transfusion | 1 | 1993 | 293 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 1990 | 187 | 0.010 |
Why?
|
Leukemia, Monocytic, Acute | 1 | 1989 | 4 | 0.010 |
Why?
|
Bradykinin | 1 | 1989 | 42 | 0.010 |
Why?
|
HIV Antigens | 1 | 1989 | 17 | 0.010 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1989 | 34 | 0.010 |
Why?
|
Arylsulfatases | 1 | 1989 | 1 | 0.010 |
Why?
|
Plasmodium falciparum | 1 | 1989 | 27 | 0.010 |
Why?
|
Thymoma | 1 | 1989 | 30 | 0.010 |
Why?
|
Acinetobacter | 1 | 1989 | 13 | 0.010 |
Why?
|
Peanut Agglutinin | 1 | 1989 | 1 | 0.010 |
Why?
|
Glutathione Reductase | 1 | 1989 | 21 | 0.010 |
Why?
|
Oligosaccharides | 1 | 1989 | 46 | 0.010 |
Why?
|
Serum Albumin, Bovine | 1 | 1989 | 61 | 0.010 |
Why?
|
Diencephalon | 1 | 1989 | 11 | 0.010 |
Why?
|
Glutathione Peroxidase | 1 | 1989 | 41 | 0.000 |
Why?
|
Carbon Radioisotopes | 1 | 1988 | 36 | 0.000 |
Why?
|
Pulse | 1 | 1988 | 27 | 0.000 |
Why?
|
Catalase | 1 | 1989 | 118 | 0.000 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 1989 | 37 | 0.000 |
Why?
|
Antigens, CD1 | 1 | 1989 | 57 | 0.000 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1988 | 53 | 0.000 |
Why?
|
Consciousness | 1 | 1988 | 20 | 0.000 |
Why?
|
Pituitary Hormones | 1 | 1988 | 16 | 0.000 |
Why?
|
Thorium Dioxide | 1 | 1968 | 1 | 0.000 |
Why?
|
Thyrotropin | 1 | 1988 | 99 | 0.000 |
Why?
|
Prostaglandin H2 | 1 | 1987 | 1 | 0.000 |
Why?
|
Prostaglandins H | 1 | 1987 | 2 | 0.000 |
Why?
|
Prostaglandin Endoperoxides, Synthetic | 1 | 1987 | 3 | 0.000 |
Why?
|
Alprostadil | 1 | 1988 | 32 | 0.000 |
Why?
|
Aldosterone | 1 | 1987 | 42 | 0.000 |
Why?
|
Synapses | 1 | 1991 | 331 | 0.000 |
Why?
|
Pulmonary Gas Exchange | 1 | 1988 | 117 | 0.000 |
Why?
|
Genes, Homeobox | 1 | 1987 | 50 | 0.000 |
Why?
|
Neurotransmitter Agents | 1 | 1988 | 75 | 0.000 |
Why?
|
Biliary Fistula | 1 | 1987 | 3 | 0.000 |
Why?
|
Haplorhini | 2 | 1979 | 57 | 0.000 |
Why?
|
Intracellular Fluid | 1 | 1987 | 27 | 0.000 |
Why?
|
Hybridomas | 1 | 1987 | 230 | 0.000 |
Why?
|
Placenta | 1 | 1993 | 628 | 0.000 |
Why?
|
Deltaretrovirus | 1 | 1987 | 12 | 0.000 |
Why?
|
Carbon Dioxide | 1 | 1988 | 218 | 0.000 |
Why?
|
Acetic Acid | 1 | 1987 | 16 | 0.000 |
Why?
|
Methylhistidines | 1 | 1986 | 1 | 0.000 |
Why?
|
Erythropoiesis | 1 | 1987 | 33 | 0.000 |
Why?
|
Receptors, Vasopressin | 1 | 1987 | 18 | 0.000 |
Why?
|
Immunoglobulin E | 1 | 1988 | 314 | 0.000 |
Why?
|
Complement Factor B | 1 | 1987 | 100 | 0.000 |
Why?
|
Vasoconstriction | 1 | 1988 | 177 | 0.000 |
Why?
|
Hemagglutination Tests | 1 | 1986 | 7 | 0.000 |
Why?
|
Erythropoietin | 1 | 1987 | 72 | 0.000 |
Why?
|
Bile Acids and Salts | 1 | 1987 | 171 | 0.000 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 1986 | 82 | 0.000 |
Why?
|
Alanine | 1 | 1986 | 104 | 0.000 |
Why?
|
Splenectomy | 1 | 1986 | 52 | 0.000 |
Why?
|
Sepharose | 1 | 1985 | 31 | 0.000 |
Why?
|
Sleep, REM | 1 | 1986 | 50 | 0.000 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1987 | 470 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1993 | 1356 | 0.000 |
Why?
|
Hematologic Tests | 1 | 1985 | 22 | 0.000 |
Why?
|
Fishes | 1 | 1986 | 80 | 0.000 |
Why?
|
Swine | 1 | 1988 | 700 | 0.000 |
Why?
|
Forearm | 1 | 1986 | 112 | 0.000 |
Why?
|
Urine | 1 | 1985 | 54 | 0.000 |
Why?
|
Hypoxia | 1 | 1991 | 958 | 0.000 |
Why?
|
Conalbumin | 1 | 1984 | 3 | 0.000 |
Why?
|
Mice, Inbred AKR | 1 | 1984 | 34 | 0.000 |
Why?
|
Immunoelectrophoresis | 1 | 1984 | 6 | 0.000 |
Why?
|
Immunoglobulin Allotypes | 1 | 1984 | 6 | 0.000 |
Why?
|
Movement | 1 | 1987 | 244 | 0.000 |
Why?
|
Anisomycin | 1 | 1984 | 3 | 0.000 |
Why?
|
Norepinephrine | 1 | 1985 | 201 | 0.000 |
Why?
|
Narcotic Antagonists | 1 | 1985 | 136 | 0.000 |
Why?
|
Salmonella enteritidis | 1 | 1983 | 16 | 0.000 |
Why?
|
Schistosomiasis | 1 | 1984 | 37 | 0.000 |
Why?
|
Chromatography, Affinity | 1 | 1983 | 80 | 0.000 |
Why?
|
Mitomycins | 1 | 1982 | 3 | 0.000 |
Why?
|
Esterases | 1 | 1982 | 11 | 0.000 |
Why?
|
Antibodies, Viral | 1 | 1986 | 520 | 0.000 |
Why?
|
Ultraviolet Rays | 1 | 1984 | 363 | 0.000 |
Why?
|
Hormones | 1 | 1981 | 132 | 0.000 |
Why?
|
Listeriosis | 1 | 1980 | 61 | 0.000 |
Why?
|
Nitroblue Tetrazolium | 1 | 1979 | 10 | 0.000 |
Why?
|
Hemocyanins | 1 | 1979 | 55 | 0.000 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1984 | 577 | 0.000 |
Why?
|
Naproxen | 1 | 1978 | 11 | 0.000 |
Why?
|
Cations, Divalent | 1 | 1978 | 51 | 0.000 |
Why?
|
Lactoferrin | 1 | 1978 | 28 | 0.000 |
Why?
|
Muramidase | 1 | 1978 | 72 | 0.000 |
Why?
|
Acetaminophen | 1 | 1979 | 241 | 0.000 |
Why?
|
Sodium Salicylate | 1 | 1975 | 1 | 0.000 |
Why?
|
Dura Mater | 1 | 1975 | 27 | 0.000 |
Why?
|
Maryland | 1 | 1974 | 37 | 0.000 |
Why?
|
Sulfadiazine | 1 | 1973 | 4 | 0.000 |
Why?
|
Diagnostic Errors | 1 | 1973 | 149 | 0.000 |
Why?
|